The	O
RAR-RXR	B-protein
as	O
well	O
as	O
the	O
RXR-RXR	B-protein
pathway	O
is	O
involved	O
in	O
signaling	O
growth	O
inhibition	O
of	O
human	B-cell_line
CD34+	I-cell_line
erythroid	I-cell_line
progenitor	I-cell_line
cells	I-cell_line
.	O

Previous	O
studies	O
have	O
shown	O
that	O
retinoic	O
acid	O
(	O
RA	O
)	O
,	O
similar	O
to	O
tumor	B-protein
necrosis	I-protein
factor-alpha	I-protein
(	O
TNF-alpha	B-protein
)	O
,	O
can	O
act	O
as	O
a	O
bifunctional	O
regulator	O
of	O
the	O
growth	O
of	O
bone	B-cell_type
marrow	I-cell_type
progenitors	I-cell_type
,	O
in	O
that	O
it	O
can	O
stimulate	O
granulocyte-macrophage	O
colony-stimulating	O
factor	O
(	O
GM-CSF	O
)	O
-	O
or	O
interleukin-3	O
(	O
IL-3	O
)	O
-induced	O
GM	O
colony	O
formation	O
,	O
but	O
potently	O
inhibit	O
G-CSF	B-protein
-induced	O
growth	O
.	O

The	O
present	O
study	O
,	O
using	O
highly	O
enriched	O
human	B-protein
CD34+	I-protein
as	O
well	O
as	O
Lin-	B-cell_line
murine	I-cell_line
bone	I-cell_line
marrow	I-cell_line
progenitor	I-cell_line
cells	I-cell_line
,	O
demonstrates	O
a	O
potent	O
inhibitory	O
effect	O
of	O
9-cis-RA	O
on	O
burst-forming	O
unit-erythroid	O
(	O
BFU-E	O
)	O
colony	O
formation	O
regardless	O
of	O
the	O
cytokine	B-protein
stimulating	O
growth	O
.	O

Specifically	O
,	O
9-cis-RA	O
potently	O
inhibited	O
the	O
growth	O
of	O
BFU-E	O
response	O
to	O
erythropoietin	B-protein
(	O
Epo	B-protein
)	O
(	O
100	O
%	O
)	O
,	O
stem	B-protein
cell	I-protein
factor	I-protein
(	O
SCF	B-protein
)	O
+	O
Epo	B-protein
(	O
92	O
%	O
)	O
,	O
IL-3	B-protein
+	O
Epo	B-protein
(	O
97	O
%	O
)	O
,	O
IL-4	B-protein
+	O
Epo	B-protein
(	O
88	O
%	O
)	O
,	O
and	O
IL-9	B-protein
+	O
Epo	B-protein
(	O
100	O
%	O
)	O
.	O

Erythroid	O
colony	O
growth	O
was	O
also	O
inhibited	O
when	O
CD34+	B-cell_type
progenitors	I-cell_type
were	O
seeded	O
at	O
one	O
cell	O
per	O
well	O
,	O
suggesting	O
a	O
direct	O
action	O
of	O
RA	O
.	O

Using	O
synthetic	O
ligands	O
to	O
retinoic	B-protein
acid	I-protein
receptors	I-protein
(	O
RARs	B-protein
)	O
and	O
retinoid	B-protein
X	I-protein
receptors	I-protein
(	O
RXRs	B-protein
)	O
that	O
selectively	O
bind	O
and	O
activate	O
RAR-RXR	B-protein
or	O
RXR-RXR	B-protein
dimers	O
,	O
respectively	O
,	O
we	O
dissected	O
the	O
involvement	O
of	O
the	O
two	O
retinoid	O
response	O
pathways	O
in	O
the	O
regulation	O
of	O
normal	O
myeloid	O
and	O
erythroid	O
progenitor	O
cell	O
growth	O
.	O

Transactivation	O
studies	O
showed	O
that	O
both	O
the	O
RAR	B-protein
(	O
Ro	O
13-7410	O
)	O
and	O
RXR	B-protein
(	O
Ro	O
25-6603	O
and	O
Ro	O
25-7386	O
)	O
ligands	O
were	O
highly	O
selective	O
at	O
100	O
nmol/L	O
.	O

At	O
this	O
concentration	O
,	O
Ro	O
13-7410	O
potently	O
inhibited	O
G-CSF	B-protein
-stimulated	O
myeloid	O
as	O
well	O
as	O
SCF	B-protein
+	O
Epo	B-protein
-induced	O
erythroid	O
colony	O
growth	O
.	O

At	O
the	O
same	O
concentration	O
,	O
Ro	O
25-6603	O
and	O
Ro	O
25-7386	O
had	O
little	O
or	O
no	O
effect	O
on	O
G-CSF	B-protein
-induced	O
colony	O
formation	O
,	O
whereas	O
they	O
inhibited	O
75	O
%	O
and	O
53	O
%	O
,	O
respectively	O
,	O
of	O
SCF	B-protein
+	O
Epo	B-protein
-stimulated	O
BFU-E	O
colony	O
growth	O
.	O

Thus	O
,	O
the	O
RAR-RXR	B-protein
response	O
pathway	O
can	O
signal	O
growth	O
inhibition	O
of	O
normal	B-cell_type
bone	I-cell_type
marrow	I-cell_type
myeloid	I-cell_type
and	I-cell_type
erythroid	I-cell_type
progenitor	I-cell_type
cells	I-cell_type
.	O

In	O
addition	O
,	O
we	O
demonstrate	O
a	O
unique	O
involvement	O
of	O
the	O
RXR-RXR	B-protein
pathway	O
in	O
mediating	O
growth	O
inhibition	O
of	O
erythroid	B-cell_type
but	O
not	O
myeloid	B-cell_type
progenitor	I-cell_type
cells	I-cell_type
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

The	NULL
RAR-RXR	NULL
as	NULL
Well	NULL
as	NULL
the	NULL
RXR-RXR	NULL
Pathway	NULL
Is	NULL
Involved	NULL
in	NULL
Signaling	NULL
Growth	NULL
Inhibition	NULL
of	NULL
Human	NULL
CD34*	NULL
Erythroid	NULL
Progenitor	NULL
Cells	NULL
By	NULL
Leiv	NULL
S.	NULL
Rusten	NULL
,	NULL
Ingunn	NULL
Dybedal	NULL
,	NULL
Heidi	NULL
Kiil	NULL
Blomhoff	NULL
,	NULL
Rune	NULL
Blomhoff	NULL
,	NULL
Erlend	NULL
B.	NULL
Smeland	NULL
,	NULL
and	NULL
Sten	NULL
Eirik	NULL
W.	NULL
Jacobsen	NULL
Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
retinoic	NULL
acid	NULL
(	NULL
RA	NULL
)	NULL
,	NULL
similar	NULL
to	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
(	NULL
TNF-a	NULL
)	NULL
,	NULL
can	NULL
act	NULL
as	NULL
a	NULL
bifunctional	NULL
regulator	NULL
of	NULL
the	NULL
growth	NULL
of	NULL
bone	NULL
marrow	NULL
progenitors	NULL
,	NULL
in	NULL
that	NULL
it	NULL
can	NULL
stimulate	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
-	NULL
or	NULL
interleukin-3	NULL
(	NULL
IL-3	NULL
)	NULL
-induced	NULL
GM	NULL
colony	NULL
formation	NULL
,	NULL
but	NULL
potently	NULL
inhibit	NULL
G-CSF-induced	NULL
growth	NULL
.	NULL

The	NULL
present	NULL
study	NULL
,	NULL
using	NULL
highly	NULL
enriched	NULL
human	NULL
CD34*	NULL
as	NULL
well	NULL
as	NULL
Lin~	NULL
murine	NULL
bone	NULL
marrow	NULL
progenitor	NULL
cells	NULL
,	NULL
demonstrates	NULL
a	NULL
potent	NULL
inhibitory	NULL
effect	NULL
of	NULL
9-cisRA	NULL
on	NULL
burst-form-ing	NULL
unit-erythroid	NULL
(	NULL
BFU-E	NULL
)	NULL
colony	NULL
formation	NULL
regardless	NULL
of	NULL
the	NULL
cytokine	NULL
stimulating	NULL
growth	NULL
.	NULL

Specifically	NULL
,	NULL
9-cis-RA	NULL
potently	NULL
inhibited	NULL
the	NULL
growth	NULL
of	NULL
BFU-E	NULL
in	NULL
response	NULL
to	NULL
erythropoietin	NULL
(	NULL
Epo	NULL
)	NULL
(	NULL
100	NULL
%	NULL
)	NULL
,	NULL
stem	NULL
cell	NULL
factor	NULL
(	NULL
SCF	NULL
)	NULL
+	NULL
Epo	NULL
(	NULL
92	NULL
%	NULL
)	NULL
,	NULL
IL-3	NULL
+	NULL
Epo	NULL
(	NULL
97	NULL
%	NULL
)	NULL
,	NULL
IL-4	NULL
+	NULL
Epo	NULL
(	NULL
88	NULL
%	NULL
)	NULL
,	NULL
and	NULL
IL-9	NULL
+	NULL
Epo	NULL
(	NULL
100	NULL
%	NULL
)	NULL
.	NULL

Erythroid	NULL
colony	NULL
growth	NULL
was	NULL
also	NULL
inhibited	NULL
when	NULL
CD34*	NULL
progenitors	NULL
were	NULL
seeded	NULL
at	NULL
one	NULL
cell	NULL
per	NULL
well	NULL
,	NULL
suggesting	NULL
a	NULL
direct	NULL
action	NULL
of	NULL
RA	NULL
.	NULL

Using	NULL
synthetic	NULL
ligands	NULL
to	NULL
retinoic	NULL
acid	NULL
receptors	NULL
{	NULL
RARs	NULL
)	NULL
and	NULL
retinoid	NULL
X	NULL
receptors	NULL
(	NULL
RXRs	NULL
)	NULL
that	NULL
selectively	NULL
bind	NULL
ETINOL	NULL
AND	NULL
ITS	NULL
derivatives	NULL
(	NULL
retinoids	NULL
)	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
exert	NULL
important	NULL
effects	NULL
in	NULL
embryogenesis	NULL
'	NULL
as	NULL
well	NULL
as	NULL
in	NULL
hematopoiesis	NULL
.	NULL
``	NULL

Retinol	NULL
is	NULL
the	NULL
major	NULL
retinoid	NULL
in	NULL
plasma	NULL
.	NULL

However	NULL
,	NULL
inside	NULL
target	NULL
cells	NULL
retinol	NULL
is	NULL
oxidized	NULL
to	NULL
the	NULL
active	NULL
metabolite	NULL
retinoic	NULL
acid	NULL
(	NULL
RA	NULL
)	NULL
.	NULL
``	NULL

The	NULL
signaling	NULL
pathway	NULL
of	NULL
RA	NULL
involves	NULL
nuclear	NULL
RA	NULL
receptors	NULL
(	NULL
RARa	NULL
,	NULL
#	NULL
,	NULL
y	NULL
)	NULL
*~	NULL
and	NULL
retinoid	NULL
X	NULL
receptors	NULL
(	NULL
RXRa	NULL
,	NULL
#	NULL
,	NULL
y	NULL
)	NULL
,	NULL
Â°	NULL
all	NULL
of	NULL
which	NULL
are	NULL
members	NULL
of	NULL
the	NULL
steroid/thyroid	NULL
hormone	NULL
receptor	NULL
superfam-ily	NULL
of	NULL
ligand-dependent	NULL
transcripion	NULL
factors	NULL
.	NULL

Recent	NULL
evidence	NULL
indicates	NULL
that	NULL
nuclear	NULL
retinoid	NULL
receptor	NULL
dimers	NULL
,	NULL
of	NULL
which	NULL
RXR	NULL
is	NULL
a	NULL
mandatory	NULL
constituent	NULL
,	NULL
are	NULL
required	NULL
for	NULL
effective	NULL
activation	NULL
of	NULL
retinoid	NULL
response	NULL
pathways	NULL
.	NULL
``	NULL

RAR-RXR	NULL
heterodimers	NULL
activate	NULL
transcription	NULL
in	NULL
response	NULL
to	NULL
all-trans-	NULL
or	NULL
9-cis-RA	NULL
by	NULL
binding	NULL
to	NULL
response	NULL
elements	NULL
in	NULL
target	NULL
genes	NULL
consisting	NULL
of	NULL
two	NULL
direct	NULL
repeats	NULL
of	NULL
the	NULL
consensus	NULL
sequence	NULL
AGGTCA	NULL
spaced	NULL
by	NULL
5	NULL
or	NULL
2	NULL
bp	NULL
(	NULL
DR5	NULL
and	NULL
DR2	NULL
elements	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
whereas	NULL
RXR-RXR	NULL
homodimers	NULL
activate	NULL
transcription	NULL
in	NULL
response	NULL
to	NULL
9-cis-RA	NULL
by	NULL
binding	NULL
to	NULL
direct	NULL
repeats	NULL
spaced	NULL
by	NULL
1	NULL
bp	NULL
(	NULL
DR1	NULL
elements	NULL
)	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
because	NULL
the	NULL
response	NULL
element	NULL
specificity	NULL
of	NULL
RAR-RXR	NULL
heterodimers	NULL
differs	NULL
from	NULL
that	NULL
of	NULL
RXR-RXR	NULL
homodimers	NULL
,	NULL
two	NULL
retinoid	NULL
response	NULL
pathways	NULL
capable	NULL
of	NULL
activating	NULL
distinct	NULL
sets	NULL
of	NULL
genes	NULL
are	NULL
thought	NULL
to	NULL
exist	NULL
.	NULL
``	NULL

From	NULL
the	NULL
Department	NULL
of	NULL
Immunology	NULL
,	NULL
Institute	NULL
for	NULL
Cancer	NULL
Research	NULL
,	NULL
The	NULL
Norwegian	NULL
Radium	NULL
Hospital	NULL
,	NULL
N-0310	NULL
Oslo	NULL
;	NULL
Institute	NULL
of	NULL
Cancer	NULL
Research	NULL
,	NULL
Medical	NULL
Technical	NULL
Center	NULL
,	NULL
N-7005	NULL
Trondheim	NULL
;	NULL
and	NULL
Institute	NULL
for	NULL
Nutrition	NULL
Research	NULL
,	NULL
University	NULL
of	NULL
Oslo	NULL
,	NULL
Norway	NULL
.	NULL

Submitted	NULL
May	NULL
1	NULL
,	NULL
1995	NULL
;	NULL
accepted	NULL
October	NULL
6	NULL
,	NULL
1995	NULL
.	NULL

Supported	NULL
by	NULL
The	NULL
Norwegian	NULL
Cancer	NULL
Society	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Leiv	NULL
S.	NULL
Rusten	NULL
,	NULL
MD	NULL
,	NULL
Department	NULL
of	NULL
Immunology	NULL
,	NULL
Institute	NULL
for	NULL
Cancer	NULL
Research	NULL
,	NULL
The	NULL
Norwegian	NULL
Radium	NULL
Hospital	NULL
,	NULL
N-0310	NULL
Oslo	NULL
,	NULL
Norway	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
'	NULL
``	NULL
'advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

Â©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
1/96/8705-0034	NULL
$	NULL
3.00/0	NULL
1728	NULL
and	NULL
activate	NULL
RAR-RXR	NULL
or	NULL
RXR-RXR	NULL
dimers	NULL
,	NULL
respectively	NULL
,	NULL
we	NULL
dissected	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
two	NULL
retinoid	NULL
response	NULL
pathways	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
normal	NULL
myeloid	NULL
and	NULL
erythroid	NULL
progenitor	NULL
cell	NULL
growth	NULL
.	NULL

Transactivation	NULL
studies	NULL
showed	NULL
that	NULL
both	NULL
the	NULL
RAR	NULL
(	NULL
Ro	NULL
13-7410	NULL
)	NULL
and	NULL
RXR	NULL
(	NULL
Ro	NULL
25-6603	NULL
and	NULL
Ro	NULL
25-7386	NULL
)	NULL
ligands	NULL
were	NULL
highly	NULL
selective	NULL
at	NULL
100	NULL
nmol/L	NULL
.	NULL

At	NULL
this	NULL
concentration	NULL
,	NULL
Ro	NULL
13-7410	NULL
potently	NULL
inhibited	NULL
G-CSF-stimulated	NULL
myeloid	NULL
as	NULL
well	NULL
as	NULL
SCF	NULL
+	NULL
Epo-induced	NULL
erythroid	NULL
colony	NULL
growth	NULL
.	NULL

At	NULL
the	NULL
same	NULL
concentration	NULL
,	NULL
Ro	NULL
25-6603	NULL
and	NULL
Ro	NULL
25-7386	NULL
had	NULL
little	NULL
or	NULL
no	NULL
effect	NULL
on	NULL
G-CSF-induced	NULL
colony	NULL
formation	NULL
,	NULL
whereas	NULL
they	NULL
inhibited	NULL
75	NULL
%	NULL
and	NULL
53	NULL
%	NULL
,	NULL
respectively	NULL
,	NULL
of	NULL
SCF	NULL
+	NULL
Epo-stimulated	NULL
BFU-E	NULL
colony	NULL
growth	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
RAR-RXR	NULL
response	NULL
pathway	NULL
can	NULL
signal	NULL
growth	NULL
inhibition	NULL
of	NULL
normal	NULL
bone	NULL
marrow	NULL
myeloid	NULL
and	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
demonstrate	NULL
a	NULL
unique	NULL
involvement	NULL
of	NULL
the	NULL
RXR-RXR	NULL
pathway	NULL
in	NULL
mediating	NULL
growth	NULL
inhibition	NULL
of	NULL
erythroid	NULL
but	NULL
not	NULL
myeloid	NULL
progenitor	NULL
cells	NULL
.	NULL

Â©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

Vitamin	NULL
A	NULL
deficiency	NULL
in	NULL
humans	NULL
and	NULL
in	NULL
experimental	NULL
animal	NULL
models	NULL
is	NULL
associated	NULL
with	NULL
anemia	NULL
,	NULL
indicating	NULL
that	NULL
retinoids	NULL
are	NULL
important	NULL
in	NULL
normal	NULL
erythroid	NULL
development	NULL
.	NULL
``	NULL

''	NULL
However	NULL
,	NULL
in	NULL
vitro	NULL
studies	NULL
have	NULL
been	NULL
inconclusive	NULL
with	NULL
regard	NULL
to	NULL
effects	NULL
of	NULL
retinoids	NULL
on	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
.	NULL

Whereas	NULL
many	NULL
previous	NULL
studies	NULL
have	NULL
reported	NULL
RA-induced	NULL
enhancement	NULL
of	NULL
erythroid	NULL
colony	NULL
formation	NULL
,	NULL
``	NULL
'~	NULL
``	NULL
others	NULL
have	NULL
found	NULL
inhibitory	NULL
effects	NULL
.	NULL

``	NULL
``	NULL
``	NULL
*	NULL
RA	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
a	NULL
bidirectional	NULL
regulator	NULL
of	NULL
the	NULL
growth	NULL
of	NULL
human	NULL
granulocyte-macrophage	NULL
(	NULL
GM	NULL
)	NULL
progenitors	NULL
.	NULL

The	NULL
response	NULL
elicited	NULL
(	NULL
stimulatory	NULL
or	NULL
inhibitory	NULL
)	NULL
is	NULL
dependent	NULL
in	NULL
part	NULL
on	NULL
the	NULL
specific	NULL
growth	NULL
factors	NULL
with	NULL
which	NULL
RA	NULL
interacts	NULL
.	NULL

Specifically	NULL
,	NULL
RA	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
either	NULL
have	NULL
no	NULL
effect	NULL
or	NULL
stimulate	NULL
interleukin-3	NULL
(	NULL
IL-3	NULL
)	NULL
-	NULL
or	NULL
GM-colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
GM	NULL
colony	NULL
formation	NULL
,	NULL
``	NULL
but	NULL
to	NULL
potently	NULL
inhibit	NULL
G-CSF-stimulated	NULL
growth	NULL
.	NULL
``	NULL

''	NULL
Similar	NULL
studies	NULL
addressing	NULL
the	NULL
direct	NULL
and	NULL
specific	NULL
interactions	NULL
of	NULL
RA	NULL
with	NULL
different	NULL
erythroid	NULL
stimuli	NULL
have	NULL
not	NULL
been	NULL
performed	NULL
.	NULL

Using	NULL
highly	NULL
purified	NULL
human	NULL
CD34*	NULL
bone	NULL
marrow	NULL
(	NULL
BM	NULL
)	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
Lin~	NULL
murine	NULL
BM	NULL
progenitors	NULL
,	NULL
we	NULL
show	NULL
here	NULL
that	NULL
RA	NULL
is	NULL
a	NULL
potent	NULL
and	NULL
direct	NULL
inhibitor	NULL
of	NULL
erythropoiesis	NULL
in	NULL
vitro	NULL
,	NULL
regardless	NULL
of	NULL
the	NULL
cytokines	NULL
stimulating	NULL
growth	NULL
.	NULL

This	NULL
effect	NULL
can	NULL
be	NULL
signaled	NULL
through	NULL
the	NULL
RAR-RXR	NULL
as	NULL
well	NULL
as	NULL
the	NULL
RXR-RXR	NULL
pathway	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
G-CSF-induced	NULL
myeloid	NULL
colony	NULL
formation	NULL
appears	NULL
to	NULL
be	NULL
inhibited	NULL
exclusively	NULL
through	NULL
the	NULL
RAR-RXR	NULL
response	NULL
pathway	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Retinoids	NULL
.	NULL

-	NULL
All-trans-RA	NULL
was	NULL
purchased	NULL
from	NULL
Sigma	NULL
(	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
,	NULL
while	NULL
9-cis-RA	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Dr	NULL
W.	NULL
Bollag	NULL
(	NULL
Hoffmann-La	NULL
Roche	NULL
,	NULL
Basel	NULL
,	NULL
Switzerland	NULL
)	NULL
.	NULL

The	NULL
RAR	NULL
selective	NULL
agonist	NULL
Ro	NULL
13-7410	NULL
(	NULL
TTNPB	NULL
)	NULL
Â®	NULL
'	NULL
and	NULL
the	NULL
RXR	NULL
selective	NULL
agonist	NULL
Ro	NULL
25-7386	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
M.	NULL
Klaus	NULL
(	NULL
Hoffmann-La	NULL
Roche	NULL
,	NULL
Basel	NULL
,	NULL
Switzerland	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
RXR	NULL
selective	NULL
agonist	NULL
Ro	NULL
25-6603	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Dr	NULL
M.	NULL
Rosenberger	NULL
(	NULL
Roche	NULL
,	NULL
Nutley	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

For	NULL
Ro	NULL
13-7410	NULL
,	NULL
the	NULL
ICs	NULL
,	NULL
binding	NULL
ratio	NULL
was	NULL
RXR/RAR	NULL
>	NULL
1,000	NULL
,	NULL
whereas	NULL
for	NULL
Ro	NULL
25-6603	NULL
as	NULL
well	NULL
as	NULL
Ro	NULL
25-7386	NULL
the	NULL
IC	NULL
,	NULL
,	NULL
binding	NULL
ratio	NULL
was	NULL
RAR/RXR	NULL
>	NULL
100	NULL
(	NULL
M.	NULL
Klaus	NULL
,	NULL
personal	NULL
communication	NULL
,	NULL
September	NULL
1994	NULL
)	NULL
.	NULL

All	NULL
retinoids	NULL
were	NULL
dissolved	NULL
in	NULL
ethanol	NULL
and	NULL
kept	NULL
at	NULL
1	NULL
to	NULL
3	NULL
mmol/L	NULL
at	NULL
-20Â°C	NULL
and	NULL
100	NULL
%	NULL
N	NULL
;	NULL
in	NULL
light-proof	NULL
containers	NULL
.	NULL

Ethanol	NULL
at	NULL
same	NULL
concentrations	NULL
Blood	NULL
,	NULL
Vol	NULL
87	NULL
,	NULL
No	NULL
5	NULL
(	NULL
March	NULL
1	NULL
)	NULL
,	NULL
1996	NULL
:	NULL
pp	NULL
1728-1736	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

RETINOIDS	NULL
INHIBIT	NULL
ERYTHROPOIESIS	NULL
as	NULL
in	NULL
retinoid-treated	NULL
cultures	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
proliferation	NULL
of	NULL
the	NULL
investigated	NULL
progenitors	NULL
{	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Hematopoietic	NULL
growth	NULL
factors	NULL
and	NULL
antibodies	NULL
.	NULL

-	NULL
Purified	NULL
recombinant	NULL
human	NULL
(	NULL
rh	NULL
)	NULL
and	NULL
rat	NULL
(	NULL
rr	NULL
)	NULL
stem	NULL
cell	NULL
factor	NULL
(	NULL
SCF	NULL
)	NULL
were	NULL
generously	NULL
supplied	NULL
by	NULL
Dr	NULL
Ian	NULL
K.	NULL
McNiece	NULL
(	NULL
Amgen	NULL
Inc	NULL
,	NULL
Thousand	NULL
Oaks	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Purified	NULL
recombinant	NULL
murine	NULL
(	NULL
rm	NULL
)	NULL
IL-3	NULL
and	NULL
IL-4	NULL
were	NULL
supplied	NULL
by	NULL
Promega	NULL
Corp	NULL
(	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
and	NULL
Boehringer	NULL
Mannheim	NULL
(	NULL
Mann-heim	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

thIL-3	NULL
was	NULL
generously	NULL
provided	NULL
by	NULL
Dr	NULL
Steven	NULL
Gillis	NULL
(	NULL
Immunex	NULL
Corp	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
.	NULL

rhIL-9	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Genetics	NULL
Institute	NULL
(	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

rh-erythropoietin	NULL
(	NULL
Epo	NULL
)	NULL
was	NULL
supplied	NULL
by	NULL
Boehringer	NULL
Mannheim	NULL
.	NULL

th	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
(	NULL
rhTNF-a	NULL
)	NULL
and	NULL
a	NULL
neutralizing	NULL
rabbit-antihuman	NULL
TNF-a	NULL
antiserum	NULL
``	NULL
were	NULL
kindly	NULL
supplied	NULL
by	NULL
Drs	NULL
W.	NULL
Lesslauer	NULL
and	NULL
H.	NULL
Loetscher	NULL
(	NULL
Hoffmann-La	NULL
Roche	NULL
)	NULL
.	NULL

The	NULL
anti-	NULL
TNF-a	NULL
antiserum	NULL
was	NULL
initially	NULL
titrated	NULL
and	NULL
thereafter	NULL
used	NULL
at	NULL
an	NULL
optimal	NULL
dilution	NULL
of	NULL
1:100	NULL
.	NULL

An	NULL
irrelevant	NULL
rabbit-antihuman	NULL
Ig	NULL
antiserum	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
.	NULL

A	NULL
neutralizing	NULL
mouse	NULL
IgG	NULL
,	NULL
monoclonal	NULL
antibody	NULL
(	NULL
MoAb	NULL
)	NULL
to	NULL
the	NULL
p55	NULL
TNF	NULL
receptor	NULL
(	NULL
TNFR55	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
Europe	NULL
(	NULL
Abingdon	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

rhTGF-3	NULL
,	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Tony	NULL
Purchio	NULL
(	NULL
Oncogene	NULL
Corp	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
.	NULL

A	NULL
neutralizing	NULL
mouse	NULL
IgG	NULL
,	NULL
MoAb	NULL
against	NULL
was	NULL
from	NULL
Genzyme	NULL
(	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

This	NULL
antibody	NULL
neutralizes	NULL
the	NULL
effects	NULL
of	NULL
mouse	NULL
as	NULL
well	NULL
as	NULL
human	NULL
TGF-	NULL
$	NULL
,	NULL
,	NULL
TGF-	NULL
$	NULL
;	NULL
,	NULL
and	NULL
TGF-B	NULL
,	NULL
.	NULL

``	NULL
>	NULL
*	NULL
An	NULL
isotype-matched	NULL
irrelevant	NULL
antihuman	NULL
a-fetoprotein	NULL
MoAb	NULL
served	NULL
as	NULL
control	NULL
.	NULL

Unless	NULL
otherwise	NULL
indicated	NULL
,	NULL
all	NULL
growth	NULL
factors	NULL
were	NULL
used	NULL
at	NULL
predetermined	NULL
optimal	NULL
concentrations	NULL
:	NULL
rhIL-3	NULL
,	NULL
20	NULL
ng/mL	NULL
;	NULL
rmIL-3	NULL
,	NULL
20	NULL
ng/mL	NULL
;	NULL
sthSCF	NULL
,	NULL
50	NULL
ng/mL	NULL
;	NULL
SCF	NULL
,	NULL
100	NULL
ng/	NULL
mL	NULL
;	NULL
rhIL-9	NULL
,	NULL
100	NULL
IU/mL	NULL
;	NULL
20	NULL
ng/mL	NULL
;	NULL
and	NULL
thEpo	NULL
,	NULL
5	NULL
IU/mL	NULL
.	NULL

For	NULL
simplicity	NULL
,	NULL
the	NULL
prefixes	NULL
designating	NULL
human	NULL
growth	NULL
factors	NULL
have	NULL
hereafter	NULL
been	NULL
deleted	NULL
.	NULL

Cell	NULL
separation	NULL
.	NULL

-	NULL
Human	NULL
BM	NULL
cells	NULL
were	NULL
obtained	NULL
by	NULL
iliac	NULL
crest	NULL
aspiration	NULL
from	NULL
normal	NULL
adult	NULL
volunteers	NULL
with	NULL
informed	NULL
consent	NULL
and	NULL
the	NULL
approval	NULL
of	NULL
the	NULL
Ethics	NULL
Committee	NULL
of	NULL
The	NULL
Norwegian	NULL
Radium	NULL
Hospital	NULL
.	NULL

Mononuclear	NULL
cells	NULL
were	NULL
isolated	NULL
by	NULL
Ficoll-Hypaque	NULL
gradient	NULL
centrifugation	NULL
(	NULL
Lymphoprep	NULL
;	NULL
Nycomed	NULL
,	NULL
Oslo	NULL
,	NULL
Norway	NULL
)	NULL
.	NULL

Positive	NULL
selection	NULL
of	NULL
CD34*	NULL
cells	NULL
was	NULL
performed	NULL
according	NULL
to	NULL
a	NULL
previously	NULL
described	NULL
method	NULL
.	NULL
``	NULL

''	NULL
Briefly	NULL
,	NULL
BM	NULL
mononuclear	NULL
cells	NULL
were	NULL
rosetted	NULL
with	NULL
Dynabeads	NULL
M-450	NULL
(	NULL
Dynal	NULL
,	NULL
Oslo	NULL
,	NULL
Norway	NULL
)	NULL
directly	NULL
coated	NULL
with	NULL
the	NULL
anti-CD34	NULL
MoAb	NULL
561Â°	NULL
for	NULL
45	NULL
minutes	NULL
at	NULL
4Â°C	NULL
on	NULL
an	NULL
apparatus	NULL
that	NULL
provided	NULL
tilting	NULL
and	NULL
gentle	NULL
rotation	NULL
.	NULL

The	NULL
bead-to-total	NULL
cell	NULL
ratio	NULL
was	NULL
1:1	NULL
.	NULL

Rosetted	NULL
cells	NULL
were	NULL
attracted	NULL
to	NULL
a	NULL
samarium	NULL
cobalt	NULL
magnet	NULL
and	NULL
nonrosetting	NULL
cells	NULL
were	NULL
removed	NULL
by	NULL
pipetting	NULL
.	NULL

Rosetted	NULL
cells	NULL
were	NULL
washed	NULL
four	NULL
times	NULL
.	NULL

Detachment	NULL
of	NULL
beads	NULL
from	NULL
positively	NULL
selected	NULL
cells	NULL
was	NULL
performed	NULL
by	NULL
incubation	NULL
with	NULL
anti-Fab	NULL
antiserum	NULL
(	NULL
DETACHaBEAD	NULL
;	NULL
Dynal	NULL
)	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
35	NULL
mg/mL	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Isolated	NULL
cells	NULL
,	NULL
free	NULL
of	NULL
beads	NULL
,	NULL
were	NULL
washed	NULL
and	NULL
counted	NULL
.	NULL

The	NULL
purity	NULL
of	NULL
CD34*	NULL
cells	NULL
isolated	NULL
by	NULL
this	NULL
method	NULL
was	NULL
reproducibly	NULL
greater	NULL
than	NULL
90	NULL
%	NULL
as	NULL
determined	NULL
by	NULL
flow	NULL
cytometric	NULL
analysis	NULL
.	NULL

Lineage	NULL
negative	NULL
(	NULL
Lin	NULL
~	NULL
)	NULL
murine	NULL
BM	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
normal	NULL
BALB/c	NULL
mice	NULL
according	NULL
to	NULL
a	NULL
previously	NULL
described	NULL
protocol	NULL
.	NULL
``	NULL

Briefly	NULL
,	NULL
low-density	NULL
BM	NULL
cells	NULL
were	NULL
obtained	NULL
using	NULL
lymphocyte	NULL
separation	NULL
medium	NULL
(	NULL
Nycomed	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
Iscove	NULL
's	NULL
Modified	NULL
Dulbecco	NULL
's	NULL
Medium	NULL
(	NULL
IMDM	NULL
;	NULL
GIBCO	NULL
,	NULL
Paisley	NULL
,	NULL
UK	NULL
)	NULL
and	NULL
resuspended	NULL
in	NULL
IMDM	NULL
supplemented	NULL
with	NULL
20	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
;	NULL
Sera-lab	NULL
,	NULL
Sussex	NULL
,	NULL
England	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
at	NULL
4Â°C	NULL
for	NULL
30	NULL
minutes	NULL
in	NULL
a	NULL
cocktail	NULL
of	NULL
predetermined	NULL
optimal	NULL
concentrations	NULL
of	NULL
antibodies	NULL
:	NULL
RA3-6B2	NULL
(	NULL
B220	NULL
antigen	NULL
;	NULL
Pharmingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
RB6-8C5	NULL
(	NULL
GR-1	NULL
antigen	NULL
;	NULL
Pharmingen	NULL
)	NULL
,	NULL
MAC-1	NULL
(	NULL
Serotec	NULL
,	NULL
Ox-fordshire	NULL
,	NULL
UK	NULL
)	NULL
,	NULL
and	NULL
L3T4	NULL
(	NULL
CD4	NULL
;	NULL
Pharmingen	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
twice	NULL
and	NULL
resuspended	NULL
in	NULL
complete	NULL
IMDM	NULL
.	NULL

Sheep-antirat	NULL
IgG	NULL
(	NULL
Fc	NULL
)	NULL
-conjugated	NULL
immunomagnetic	NULL
beads	NULL
(	NULL
Dynal	NULL
)	NULL
were	NULL
added	NULL
at	NULL
a	NULL
cell/	NULL
bead	NULL
ratio	NULL
of	NULL
1:10	NULL
,	NULL
and	NULL
incubated	NULL
at	NULL
4Â°C	NULL
for	NULL
30	NULL
minutes	NULL
.	NULL

Labeled	NULL
(	NULL
Lin*	NULL
)	NULL
cells	NULL
were	NULL
removed	NULL
by	NULL
a	NULL
samarium	NULL
cobalt	NULL
magnet	NULL
(	NULL
Dynal	NULL
)	NULL
,	NULL
and	NULL
the	NULL
Lin~	NULL
cells	NULL
recovered	NULL
from	NULL
the	NULL
supernatant	NULL
.	NULL

Colony	NULL
assay	NULL
.	NULL

-	NULL
Human	NULL
CD34*	NULL
cells	NULL
or	NULL
Lin~	NULL
murine	NULL
cells	NULL
were	NULL
plated	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
1	NULL
mL	NULL
IMDM	NULL
(	NULL
GIBCO	NULL
)	NULL
containing	NULL
20	NULL
%	NULL
FCS	NULL
1729	NULL
(	NULL
Sera-lab	NULL
)	NULL
1.0	NULL
%	NULL
methylcellulose	NULL
(	NULL
Methocel	NULL
4,000	NULL
mPa	NULL
+s	NULL
;	NULL
Fluka	NULL
AG	NULL
,	NULL
Buchs	NULL
,	NULL
Switzerland	NULL
)	NULL
,	NULL
5	NULL
x	NULL
10~	NULL
mol/L	NULL
2-mercaptoethanol	NULL
,	NULL
300	NULL
mg/	NULL
L	NULL
glutamine	NULL
,	NULL
66	NULL
mg/L	NULL
penicillin	NULL
,	NULL
and	NULL
100	NULL
mg/L	NULL
streptomycin	NULL
,	NULL
and	NULL
recombinant	NULL
growth	NULL
factors	NULL
as	NULL
indicated	NULL
.	NULL

Serum-deprived	NULL
cultures	NULL
were	NULL
set	NULL
up	NULL
in	NULL
X-Vivo	NULL
15	NULL
medium	NULL
(	NULL
BioWhittaker	NULL
,	NULL
Inc	NULL
,	NULL
Walkersville	NULL
,	NULL
MD	NULL
)	NULL
containing	NULL
1	NULL
%	NULL
detoxified	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
Stem	NULL
Cell	NULL
Technologies	NULL
,	NULL
Vancouver	NULL
,	NULL
Canada	NULL
)	NULL
,	NULL
1	NULL
%	NULL
methylcellulose	NULL
,	NULL
glutamine	NULL
,	NULL
streptomycin	NULL
,	NULL
and	NULL
penicillin	NULL
.	NULL

After	NULL
1	NULL
or	NULL
2	NULL
weeks	NULL
of	NULL
incubation	NULL
at	NULL
37Â°C	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
air	NULL
,	NULL
erythroid-	NULL
or	NULL
G-CSF-induced	NULL
colonies	NULL
(	NULL
>	NULL
40	NULL
cells	NULL
)	NULL
were	NULL
assessed	NULL
as	NULL
previously	NULL
described*	NULL
``	NULL
and	NULL
counted	NULL
using	NULL
an	NULL
inverted	NULL
microscope	NULL
.	NULL

Single-cell	NULL
proliferation	NULL
assay	NULL
.	NULL

|	NULL
Test	NULL
cells	NULL
were	NULL
seeded	NULL
in	NULL
Tera-saki	NULL
plates	NULL
(	NULL
Nunc	NULL
,	NULL
Kamstrup	NULL
,	NULL
Denmark	NULL
)	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
1	NULL
cell	NULL
per	NULL
well	NULL
(	NULL
300	NULL
wells	NULL
per	NULL
group	NULL
)	NULL
in	NULL
20	NULL
gL	NULL
IMDM	NULL
containing	NULL
20	NULL
%	NULL
FCS	NULL
(	NULL
Sera-lab	NULL
)	NULL
,	NULL
L-glutamine	NULL
,	NULL
penicillin	NULL
,	NULL
and	NULL
streptomycin	NULL
(	NULL
complete	NULL
IMDM	NULL
)	NULL
.	NULL

Wells	NULL
were	NULL
scored	NULL
for	NULL
erythroid	NULL
colony	NULL
formation	NULL
(	NULL
>	NULL
40	NULL
cells	NULL
)	NULL
after	NULL
2	NULL
weeks	NULL
of	NULL
incubation	NULL
at	NULL
37Â°C	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
air	NULL
.	NULL

To	NULL
verify	NULL
the	NULL
erythroid	NULL
composition	NULL
of	NULL
colonies	NULL
induced	NULL
by	NULL
SCF	NULL
+	NULL
Epo	NULL
,	NULL
morphological	NULL
examination	NULL
of	NULL
randomly	NULL
picked	NULL
colonies	NULL
was	NULL
performed	NULL
on	NULL
May-Griinwald-Giemsa-stained	NULL
cytocentrifuge	NULL
cell	NULL
preparations	NULL
.	NULL

Cell	NULL
phenotyping	NULL
.	NULL

-	NULL
CD34*	NULL
cells	NULL
were	NULL
plated	NULL
at	NULL
10	NULL
%	NULL
cells	NULL
in	NULL
1	NULL
mL	NULL
of	NULL
complete	NULL
IMDM	NULL
supplemented	NULL
with	NULL
optimal	NULL
concentrations	NULL
of	NULL
SCF	NULL
+	NULL
Epo	NULL
and	NULL
incubated	NULL
for	NULL
2	NULL
weeks	NULL
at	NULL
37Â°C	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
air	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
9-cis-RA	NULL
{	NULL
10	NULL
nmol/L	NULL
)	NULL
.	NULL

Cell	NULL
morphology	NULL
was	NULL
determined	NULL
after	NULL
May-OGriinwald-Giemsa-staining	NULL
of	NULL
cytospin	NULL
preparations	NULL
.	NULL

Transactivation	NULL
assays	NULL
for	NULL
retinoids	NULL
.	NULL

-	NULL
P19	NULL
cells	NULL
were	NULL
trypsinized	NULL
in	NULL
medium	NULL
containing	NULL
5	NULL
%	NULL
delipidated	NULL
FCS	NULL
4	NULL
hours	NULL
before	NULL
transfec-tion	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
15	NULL
ug	NULL
of	NULL
either	NULL
CRBP	NULL
(	NULL
IN	NULL
)	NULL
-chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
reporter	NULL
vector	NULL
``	NULL
(	NULL
containing	NULL
RXRE	NULL
or	NULL
DRI	NULL
,	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
Dr	NULL
David	NULL
J.	NULL
Mangelsdorf	NULL
,	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Dallas	NULL
,	NULL
TX	NULL
)	NULL
or	NULL
the	NULL
RAR	NULL
,	NULL
/32-LacZ	NULL
reporter	NULL
vector	NULL
``	NULL
(	NULL
containing	NULL
RARE	NULL
or	NULL
DR5	NULL
,	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
Dr	NULL
Pierre	NULL
Chambon	NULL
,	NULL
CNRS	NULL
,	NULL
Strasbourg	NULL
,	NULL
France	NULL
)	NULL
using	NULL
the	NULL
calcium	NULL
phosphate	NULL
method	NULL
as	NULL
described	NULL
.	NULL
``	NULL

''	NULL
In	NULL
addition	NULL
to	NULL
the	NULL
reporter	NULL
vectors	NULL
,	NULL
2	NULL
ug	NULL
RARa	NULL
or	NULL
expression	NULL
vectors	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
Pierre	NULL
Chambon	NULL
)	NULL
were	NULL
cotransfected	NULL
into	NULL
P19	NULL
cells	NULL
,	NULL
together	NULL
with	NULL
1	NULL
ug	NULL
LacZ	NULL
vector	NULL
(	NULL
pCH110	NULL
;	NULL
Pharmacia	NULL
Biotech	NULL
Inc	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
or	NULL
pSV2-CAT	NULL
vector	NULL
cotransfected	NULL
as	NULL
internal	NULL
standards	NULL
.	NULL

Twenty	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
incubated	NULL
with	NULL
the	NULL
same	NULL
medium	NULL
containing	NULL
100	NULL
nmol/L	NULL
of	NULL
the	NULL
indicated	NULL
retinoid	NULL
.	NULL

Reporter	NULL
enzyme	NULL
activities	NULL
were	NULL
measured	NULL
after	NULL
24	NULL
hours	NULL
of	NULL
incubation	NULL
with	NULL
retinoids	NULL
.	NULL

CAT	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
to	NULL
determine	NULL
DR1-mediated	NULL
transcription	NULL
.	NULL

LacZ	NULL
activity	NULL
was	NULL
measured	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
description	NULL
(	NULL
Pharmacia	NULL
)	NULL
to	NULL
determine	NULL
DR5-induced	NULL
transcription	NULL
.	NULL

Statistical	NULL
analysis	NULL
.	NULL

-	NULL
Unless	NULL
otherwise	NULL
indicated	NULL
,	NULL
results	NULL
were	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
data	NULL
obtained	NULL
from	NULL
three	NULL
or	NULL
more	NULL
separate	NULL
experiments	NULL
.	NULL

The	NULL
statistical	NULL
significance	NULL
of	NULL
differences	NULL
between	NULL
groups	NULL
was	NULL
determined	NULL
using	NULL
the	NULL
paired	NULL
H-test	NULL
.	NULL

RESULTS	NULL
Effects	NULL
of	NULL
9-cis-RA	NULL
on	NULL
erythroid	NULL
colony	NULL
formation	NULL
by	NULL
human	NULL
BM	NULL
CD34*	NULL
cells	NULL
.	NULL

Conflicting	NULL
data	NULL
have	NULL
previously	NULL
been	NULL
reported	NULL
with	NULL
regard	NULL
to	NULL
effects	NULL
of	NULL
RA	NULL
on	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
.	NULL

Regardless	NULL
of	NULL
the	NULL
isoform	NULL
tested	NULL
,	NULL
several	NULL
investigators	NULL
found	NULL
that	NULL
RA	NULL
could	NULL
enhance	NULL
Epo-induced	NULL
burst-promoting	NULL
activity	NULL
.	NULL
``	NULL

''	NULL
Conversely	NULL
,	NULL
other	NULL
studies	NULL
have	NULL
demonstrated	NULL
inhibitory	NULL
effects	NULL
of	NULL
RA	NULL
on	NULL
erythroid	NULL
colony	NULL
formation	NULL
.	NULL
``	NULL

Whether	NULL
the	NULL
specific	NULL
growth	NULL
factors	NULL
by	NULL
which	NULL
RA	NULL
interacts	NULL
can	NULL
explain	NULL
these	NULL
different	NULL
effects	NULL
on	NULL
erythroid	NULL
progenitors	NULL
has	NULL
not	NULL
previously	NULL
been	NULL
addressed	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
9-cis-RA	NULL
inhibited	NULL
BFU-E	NULL
colony	NULL
formation	NULL
of	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1730	NULL
CD34*	NULL
BM	NULL
cells	NULL
induced	NULL
by	NULL
multiple	NULL
cytokine	NULL
combinations	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

Specifically	NULL
,	NULL
BFU-E	NULL
colony	NULL
growth	NULL
induced	NULL
by	NULL
Epo	NULL
alone	NULL
or	NULL
Epo	NULL
in	NULL
combination	NULL
with	NULL
IL-9	NULL
was	NULL
completely	NULL
inhibited	NULL
by	NULL
9-cis-RA	NULL
(	NULL
100	NULL
nmol/L	NULL
)	NULL
,	NULL
whereas	NULL
BFU-E	NULL
colony	NULL
formation	NULL
stimulated	NULL
by	NULL
Epo	NULL
+	NULL
SCF	NULL
,	NULL
Epo	NULL
+	NULL
IL-3	NULL
,	NULL
and	NULL
Epo	NULL
+	NULL
IL-3	NULL
+	NULL
IL-9	NULL
+	NULL
SCF	NULL
was	NULL
inhibited	NULL
by	NULL
92	NULL
%	NULL
(	NULL
P	NULL
<	NULL
.05	NULL
)	NULL
,	NULL
97	NULL
%	NULL
(	NULL
P	NULL
<	NULL
.05	NULL
)	NULL
,	NULL
and	NULL
42	NULL
%	NULL
(	NULL
P	NULL
<	NULL
.05	NULL
)	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

9-cis-RA	NULL
inhibited	NULL
BFU-E	NULL
colony	NULL
formation	NULL
in	NULL
a	NULL
concentration-dependent	NULL
fashion	NULL
.	NULL

Fifty	NULL
percent	NULL
inhibition	NULL
of	NULL
Epo	NULL
+	NULL
SCF-stimulated	NULL
colony	NULL
growth	NULL
occurred	NULL
at	NULL
a	NULL
9-cis-RA	NULL
concentration	NULL
of	NULL
1	NULL
to	NULL
10	NULL
nmol/L	NULL
,	NULL
whereas	NULL
complete	NULL
inhibition	NULL
of	NULL
erythroid	NULL
colony-forming	NULL
ability	NULL
was	NULL
observed	NULL
at	NULL
1,000	NULL
nmol/L	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

In	NULL
comparison	NULL
,	NULL
50	NULL
%	NULL
inhibition	NULL
of	NULL
SCF	NULL
+	NULL
IL-3	NULL
+	NULL
IL-9	NULL
+	NULL
Epo-induced	NULL
BFU-E	NULL
colony	NULL
growth	NULL
was	NULL
observed	NULL
at	NULL
a	NULL
9-cis-RA	NULL
concentration	NULL
of	NULL
100	NULL
nmol/L	NULL
,	NULL
and	NULL
an	NULL
inhibition	NULL
of	NULL
86	NULL
%	NULL
occurred	NULL
at	NULL
1,000	NULL
nmol/L	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

Although	NULL
CD34	NULL
*	NULL
cells	NULL
represent	NULL
a	NULL
highly	NULL
enriched	NULL
population	NULL
of	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
,	NULL
there	NULL
is	NULL
still	NULL
considerable	NULL
heterogeneity	NULL
within	NULL
the	NULL
CD34*	NULL
cell	NULL
compartment	NULL
.	NULL

Therefore	NULL
,	NULL
indirect	NULL
effects	NULL
through	NULL
cytokine	NULL
production	NULL
from	NULL
accessory	NULL
cells	NULL
can	NULL
not	NULL
be	NULL
excluded	NULL
when	NULL
effects	NULL
of	NULL
RA	NULL
are	NULL
studied	NULL
using	NULL
CD34*	NULL
cells	NULL
at	NULL
high	NULL
density	NULL
.	NULL

However	NULL
,	NULL
no	NULL
previous	NULL
study	NULL
has	NULL
determined	NULL
whether	NULL
effects	NULL
of	NULL
RA	NULL
on	NULL
erythroid	NULL
progenitors	NULL
are	NULL
directly	NULL
mediated	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
9-cis-RA	NULL
(	NULL
100	NULL
nmol/L	NULL
)	NULL
on	NULL
SCF	NULL
+	NULL
Epo-stimulated	NULL
erythroid	NULL
colony	NULL
formation	NULL
of	NULL
CD34*	NULL
progenitor	NULL
cells	NULL
plated	NULL
at	NULL
1	NULL
cell	NULL
per	NULL
well	NULL
were	NULL
examined	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
colony	NULL
assays	NULL
,	NULL
9-cis-RA	NULL
inhibited	NULL
SCF	NULL
+	NULL
Epo-induced	NULL
erythroid	NULL
colony	NULL
formation	NULL
of	NULL
single	NULL
CD34*	NULL
cells	NULL
by	NULL
96	NULL
%	NULL
(	NULL
P	NULL
<	NULL
.05	NULL
;	NULL
Fig	NULL
3	NULL
)	NULL
,	NULL
suggesting	NULL
a	NULL
direct	NULL
inhibitory	NULL
effect	NULL
of	NULL
9-cis-RA	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
9-cis-RA	NULL
also	NULL
could	NULL
affect	NULL
the	NULL
differentiation	NULL
of	NULL
erythroid	NULL
progenitors	NULL
,	NULL
CD34*	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
SCF	NULL
+	NULL
Epo	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
9-cisRA	NULL
(	NULL
10	NULL
nmol/L	NULL
)	NULL
for	NULL
1	NULL
or	NULL
2	NULL
weeks	NULL
,	NULL
and	NULL
cytospin	NULL
preparations	NULL
from	NULL
three	NULL
separate	NULL
experiments	NULL
were	NULL
analyzed	NULL
morphologi-	NULL
100	NULL
C	NULL
Epo	NULL
e	NULL
I	NULL
it-9+Epo	NULL
5	NULL
gy	NULL
E	NULL
scr+Epo	NULL
8	NULL
-	NULL
so	NULL
#	NULL
iL-3+Epo	NULL
g	NULL
Z	NULL
p	NULL
IL-3+|:9	NULL
&	NULL
401	NULL
Ã©	NULL
+SCF+Epo	NULL
8	NULL
,	NULL
g	NULL
``	NULL
1	NULL
Z	NULL
9-cis-RA	NULL
Fig	NULL
1	NULL
.	NULL

Effects	NULL
of	NULL
9-cissRA	NULL
on	NULL
BFU-E	NULL
colony	NULL
formation	NULL
of	NULL
CD34	NULL
human	NULL
BM	NULL
cells	NULL
.	NULL

CD34*	NULL
cells	NULL
were	NULL
isolated	NULL
and	NULL
plated	NULL
in	NULL
methylcellulose	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
at	NULL
2	NULL
x	NULL
10Â°	NULL
cells/plate	NULL
with	NULL
predetermined	NULL
optimal	NULL
concentrations	NULL
of	NULL
the	NULL
growth	NULL
factors	NULL
indicated	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
prasence	NULL
of	NULL
9-cis-RA	NULL
{	NULL
100	NULL
nmol/L	NULL
)	NULL
.	NULL

Cultures	NULL
were	NULL
scored	NULL
for	NULL
BFU-E	NULL
colonies	NULL
after	NULL
14	NULL
days	NULL
of	NULL
incubation	NULL
at	NULL
37Â°C	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
air	NULL
.	NULL

Results	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
absolute	NULL
number	NULL
of	NULL
BFU-E	NULL
colonies	NULL
formed	NULL
per	NULL
2	NULL
x	NULL
10Â°	NULL
cells	NULL
and	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
with	NULL
triplicate	NULL
determinations	NULL
;	NULL
error	NULL
bars	NULL
show	NULL
the	NULL
SEM	NULL
.	NULL

*	NULL
,	NULL
No	NULL
colony	NULL
formation	NULL
.	NULL

RUSTEN	NULL
ET	NULL
AL	NULL
100	NULL
No	NULL
.	NULL

of	NULL
BFU-E	NULL
colonies	NULL
0	NULL
-~	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
0	NULL
10	NULL
)	NULL
100	NULL
101	NULL
102	NULL
103	NULL
9-cis-RA	NULL
,	NULL
nM	NULL
Fig	NULL
2	NULL
.	NULL

Concentration-response	NULL
of	NULL
9-cis-RA~-induced	NULL
inhibition	NULL
of	NULL
BFU-E	NULL
colony	NULL
formation	NULL
.	NULL

CD34*	NULL
human	NULL
BM	NULL
cells	NULL
were	NULL
separated	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
and	NULL
cultured	NULL
at	NULL
2	NULL
x	NULL
10Â°	NULL
cells/	NULL
plate	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
predetermined	NULL
optimal	NULL
concentrations	NULL
of	NULL
(	NULL
O	NULL
}	NULL
SCF	NULL
+	NULL
Epo	NULL
,	NULL
or	NULL
(	NULL
C	NULL
)	NULL
SCF	NULL
+	NULL
IL-3	NULL
+	NULL
IL-9	NULL
+	NULL
Epo	NULL
,	NULL
and	NULL
increasing	NULL
concentrations	NULL
of	NULL
9-cis-RA	NULL
.	NULL

Cultures	NULL
were	NULL
scored	NULL
for	NULL
BFU-E	NULL
colony	NULL
growth	NULL
after	NULL
14	NULL
days	NULL
of	NULL
incubation	NULL
at	NULL
37Â°C	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
;	NULL
in	NULL
air	NULL
.	NULL

Results	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
absolute	NULL
number	NULL
(	NULL
+SEM	NULL
)	NULL
of	NULL
BFU-E	NULL
colonies	NULL
formed	NULL
,	NULL
and	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
with	NULL
triplicate	NULL
determinations	NULL
.	NULL

cally	NULL
.	NULL

After	NULL
1	NULL
week	NULL
,	NULL
the	NULL
proportion	NULL
of	NULL
terminally	NULL
differentiated	NULL
erythroblasts	NULL
characterized	NULL
by	NULL
pyknotic	NULL
nuclei	NULL
was	NULL
17	NULL
%	NULL
+	NULL
3	NULL
%	NULL
in	NULL
control	NULL
cultures	NULL
and	NULL
30	NULL
%	NULL
+	NULL
5	NULL
%	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
9-cis-RA	NULL
.	NULL

Similarly	NULL
,	NULL
after	NULL
2	NULL
weeks	NULL
'	NULL
incubation	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
9-cis-RA	NULL
,	NULL
52	NULL
%	NULL
+	NULL
10	NULL
%	NULL
and	NULL
80	NULL
%	NULL
*+	NULL
5	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
,	NULL
respectively	NULL
,	NULL
were	NULL
terminally	NULL
differentiated	NULL
erythro-blasts	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
9-cis-RA	NULL
inhibited	NULL
total	NULL
cell	NULL
proliferation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
it	NULL
did	NULL
not	NULL
inhibit	NULL
the	NULL
production	NULL
of	NULL
end-stage	NULL
erythroblasts	NULL
in	NULL
those	NULL
clones	NULL
that	NULL
proliferated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
RA	NULL
.	NULL

Effects	NULL
of	NULL
9-cis-RA	NULL
on	NULL
erythroid	NULL
colony	NULL
formation	NULL
by	NULL
murine	NULL
Lin~	NULL
BM	NULL
cells	NULL
.	NULL

In	NULL
a	NULL
previous	NULL
study	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
a	NULL
potent	NULL
and	NULL
direct	NULL
inhibitory	NULL
effect	NULL
of	NULL
9-cis-	NULL
and	NULL
all-trans-RA	NULL
on	NULL
the	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
primitive	NULL
Lin~	NULL
Sca-1*	NULL
murine	NULL
progenitor	NULL
cells	NULL
.	NULL
``	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
RA	NULL
also	NULL
inhibits	NULL
colony	NULL
formation	NULL
of	NULL
committed	NULL
erythroid	NULL
progenitors	NULL
in	NULL
murine	NULL
BM	NULL
.	NULL

Specifically	NULL
,	NULL
9-cis-RA	NULL
(	NULL
1	NULL
umol/L	NULL
)	NULL
inhibited	NULL
BFU-E	NULL
colony	NULL
formation	NULL
stimulated	NULL
by	NULL
rmIL-4	NULL
+	NULL
Epo	NULL
,	NULL
TSCF	NULL
+	NULL
Epo	NULL
,	NULL
and	NULL
rmIL-3	NULL
+	NULL
Epo	NULL
by	NULL
88	NULL
%	NULL
,	NULL
89	NULL
%	NULL
,	NULL
and	NULL
78	NULL
%	NULL
,	NULL
respectively	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
as	NULL
in	NULL
the	NULL
human	NULL
system	NULL
,	NULL
RA	NULL
can	NULL
inhibit	NULL
murine	NULL
in	NULL
vitro	NULL
erythropoiesis	NULL
stimulated	NULL
by	NULL
multiple	NULL
cytokine	NULL
combinations	NULL
.	NULL

The	NULL
inhibitory	NULL
effects	NULL
of	NULL
RA	NULL
on	NULL
CD34*	NULL
BFU-E	NULL
are	NULL
not	NULL
mediated	NULL
through	NULL
TGF-L	NULL
or	NULL
TNF-a	NULL
.	NULL

-	NULL
Although	NULL
the	NULL
results	NULL
of	NULL
single-cell	NULL
cloning	NULL
experiments	NULL
suggested	NULL
a	NULL
direct	NULL
action	NULL
of	NULL
RA	NULL
on	NULL
the	NULL
progenitor	NULL
cells	NULL
,	NULL
this	NULL
assay	NULL
can	NULL
not	NULL
show	NULL
effects	NULL
mediated	NULL
via	NULL
autocrine	NULL
loops	NULL
.	NULL

Since	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
human	NULL
CD34*	NULL
progenitor	NULL
cells	NULL
themselves	NULL
can	NULL
produce	NULL
TGF-8	NULL
,	NULL
,	NULL
*	NULL
and	NULL
that	NULL
RA	NULL
can	NULL
induce	NULL
protein	NULL
production	NULL
in	NULL
a	NULL
human	NULL
myeloid	NULL
leukemia	NULL
cell	NULL
line	NULL
(	NULL
HL-60	NULL
)	NULL
,4	NULL
we	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

RETINOIDS	NULL
INHIBIT	NULL
ERYTHROPOIESIS	NULL
Ã©	NULL
10	NULL
-	NULL
/	NULL
2	NULL
o	NULL
.	NULL

%	NULL
mrraizm	NULL
SCF+Epo	NULL
+9-cis-RA	NULL
Fig	NULL
3	NULL
.	NULL

Effect	NULL
of	NULL
9-cis-RA	NULL
on	NULL
erythroid	NULL
colony	NULL
formation	NULL
of	NULL
CD34*	NULL
BM	NULL
cells	NULL
in	NULL
single-cell	NULL
assay	NULL
.	NULL

CD34*	NULL
cells	NULL
were	NULL
isolated	NULL
and	NULL
plated	NULL
at	NULL
one	NULL
cell	NULL
per	NULL
well	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
predetermined	NULL
optimal	NULL
concentrations	NULL
of	NULL
SCF	NULL
+	NULL
Epo	NULL
and	NULL
SCF	NULL
+	NULL
Epo	NULL
+	NULL
9-cis-RA	NULL
(	NULL
100	NULL
nmol/L	NULL
}	NULL
as	NULL
indicated	NULL
.	NULL

Erythroid	NULL
colonies	NULL
(	NULL
>	NULL
40	NULL
cells	NULL
)	NULL
were	NULL
assessed	NULL
(	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
and	NULL
counted	NULL
after	NULL
14	NULL
days	NULL
of	NULL
incubation	NULL
at	NULL
37Â°C	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
air	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
individual	NULL
colonies	NULL
were	NULL
picked	NULL
to	NULL
determine	NULL
that	NULL
all	NULL
colonies	NULL
formed	NULL
were	NULL
in	NULL
fact	NULL
erythroid	NULL
.	NULL

Each	NULL
group	NULL
consisted	NULL
of	NULL
300	NULL
wells	NULL
,	NULL
and	NULL
results	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
mean	NULL
number	NULL
of	NULL
positive	NULL
wells	NULL
in	NULL
three	NULL
separate	NULL
experiments	NULL
;	NULL
error	NULL
bars	NULL
show	NULL
the	NULL
SEM	NULL
.	NULL

next	NULL
examined	NULL
whether	NULL
the	NULL
observed	NULL
effects	NULL
of	NULL
9-cis-RA	NULL
might	NULL
be	NULL
mediated	NULL
through	NULL
a	NULL
TGF-	NULL
autocrine	NULL
loop	NULL
.	NULL

Furthermore	NULL
,	NULL
because	NULL
the	NULL
effects	NULL
of	NULL
TNF-	NULL
Â«	NULL
on	NULL
hematopoiesis	NULL
,	NULL
mainly	NULL
mediated	NULL
through	NULL
TNFR55	NULL
,	NULL
***	NULL
partially	NULL
mimic	NULL
those	NULL
of	NULL
RA	NULL
in	NULL
that	NULL
it	NULL
potently	NULL
inhibits	NULL
erythroid	NULL
colony	NULL
formation	NULL
as	NULL
well	NULL
as	NULL
G-CSF-induced	NULL
proliferation	NULL
,	NULL
we	NULL
also	NULL
investigated	NULL
whether	NULL
endogeneous	NULL
TNFR55-mediated	NULL
signaling	NULL
might	NULL
be	NULL
involved	NULL
in	NULL
mediating	NULL
the	NULL
effects	NULL
of	NULL
9-cis-RA	NULL
.	NULL

TGF-8	NULL
,	NULL
(	NULL
0.2	NULL
ng/mL	NULL
)	NULL
inhibited	NULL
SCF	NULL
+	NULL
Epo-induced	NULL
BFU-E	NULL
colony	NULL
growth	NULL
by	NULL
79	NULL
%	NULL
,	NULL
and	NULL
this	NULL
effect	NULL
could	NULL
be	NULL
abrogated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
neutralizing	NULL
anti-TGF-8	NULL
antibody	NULL
(	NULL
2	NULL
ug/mL	NULL
;	NULL
Fig	NULL
4A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
this	NULL
antibody	NULL
had	NULL
little	NULL
or	NULL
no	NULL
effect	NULL
on	NULL
Table	NULL
1	NULL
.	NULL

Effects	NULL
of	NULL
9-cis-RA	NULL
on	NULL
Erythroid	NULL
Colony	NULL
Formation	NULL
of	NULL
Lin~	NULL
Murine	NULL
BM	NULL
Cells	NULL
No	NULL
.	NULL

of	NULL
BFU-E	NULL
Colonies	NULL
Growth	NULL
Factors	NULL
-RA	NULL
+RA	NULL
Epo	NULL
0	NULL
(	NULL
0	NULL
)	NULL
0	NULL
(	NULL
0	NULL
)	NULL
Epo	NULL
+	NULL
rmIl-4	NULL
25	NULL
(	NULL
2	NULL
)	NULL
3	NULL
(	NULL
2	NULL
)	NULL
Epo	NULL
+	NULL
rSCF	NULL
36	NULL
(	NULL
4	NULL
)	NULL
4	NULL
(	NULL
1	NULL
)	NULL
Epo	NULL
+	NULL
rmIL-3	NULL
37	NULL
(	NULL
4	NULL
)	NULL
8	NULL
(	NULL
3	NULL
)	NULL
Lin~	NULL
BM	NULL
cells	NULL
were	NULL
separated	NULL
and	NULL
plated	NULL
at	NULL
20,000	NULL
cells	NULL
per	NULL
dish	NULL
(	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
9-cis-RA	NULL
at	NULL
1	NULL
pmol/L	NULL
because	NULL
this	NULL
was	NULL
demonstrated	NULL
to	NULL
give	NULL
optimal	NULL
inhibition	NULL
.	NULL

However	NULL
,	NULL
10	NULL
nmol/L	NULL
and	NULL
100	NULL
nmol/L	NULL
also	NULL
resulted	NULL
in	NULL
significant	NULL
,	NULL
but	NULL
less	NULL
,	NULL
inhibition	NULL
{	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Individual	NULL
cultures	NULL
were	NULL
supplemented	NULL
with	NULL
predetermined	NULL
optimal	NULL
concentrations	NULL
of	NULL
the	NULL
growth	NULL
factors	NULL
indicated	NULL
and	NULL
scored	NULL
for	NULL
BFU-E	NULL
colony	NULL
growth	NULL
(	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
after	NULL
8	NULL
days	NULL
of	NULL
incubation	NULL
at	NULL
37Â°C	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
air	NULL
.	NULL

The	NULL
results	NULL
represent	NULL
the	NULL
mean	NULL
number	NULL
of	NULL
BFU-E	NULL
colonies	NULL
(	NULL
SEM	NULL
}	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
with	NULL
triplicate	NULL
determinations	NULL
.	NULL

1731	NULL
the	NULL
inhibition	NULL
by	NULL
9-cis-RA	NULL
on	NULL
SCF	NULL
+	NULL
Epo-induced	NULL
BFU-E	NULL
colony	NULL
growth	NULL
(	NULL
Fig	NULL
4A	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
TNF-a	NULL
(	NULL
20	NULL
ng/mL	NULL
)	NULL
inhibited	NULL
92	NULL
%	NULL
of	NULL
SCF	NULL
+	NULL
Epo-induced	NULL
BFU-E	NULL
colony	NULL
formation	NULL
,	NULL
and	NULL
this	NULL
effect	NULL
could	NULL
be	NULL
neutralized	NULL
by	NULL
supplementing	NULL
an	NULL
anti-TNF-a	NULL
antiserum	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
inhibition	NULL
by	NULL
9-cis-RA	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
anti-TNF-a	NULL
antiserum	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
a	NULL
neutralizing	NULL
anti-TNFR55	NULL
antibody	NULL
partially	NULL
reversed	NULL
TNF-a-induced	NULL
inhibition	NULL
,	NULL
but	NULL
not	NULL
9-cis	NULL
A	NULL
Epo+SCF	NULL
Epo+SCF+9-cis-RA	NULL
Epo+SCF+9-cis-RA+anti-	NULL
TGF-6	NULL
Epo+SCF+TGF-B	NULL
Epo+SCF+TGF-B+anti-TGF-	NULL
$	NULL
W	NULL
%	NULL
WW	NULL
Epo+SCF+anti-	NULL
TGF-	NULL
nggg	NULL
Z	NULL
%	NULL
0	NULL
so	NULL
10	NULL
20	NULL
30	NULL
40	NULL
7	NULL
B	NULL
Epo+SCF	NULL
Epo+SCF+9-cis-RA	NULL
Epo+SCF+9-cis-RA+anti-	NULL
TNF-a	NULL
Epo+SCF+	NULL
TNF-a	NULL
&	NULL
Epo+SCF+	NULL
TNF-oanti-	NULL
TNF-o	NULL
Epo+SCF+anti-	NULL
TNF-a	NULL
W7/	NULL
//	NULL
0	NULL
0	NULL
20	NULL
30	NULL
40	NULL
1	NULL
Epo+SCF	NULL
Epo+SCF+9-cis-RA	NULL
Epo+SCF+9-cis-RA+anti-	NULL
TNFR55	NULL
Epo+SCF+	NULL
TNF-a	NULL
Epo+SCF+	NULL
TNF-aanti-TNFR5S	NULL
W	NULL
T	NULL
10	NULL
20	NULL
30	NULL
40	NULL
50	NULL
60	NULL
BSSSS	NULL
No	NULL
.	NULL

of	NULL
BFU-E	NULL
colonies	NULL
Fig	NULL
4	NULL
.	NULL

-	NULL
Effects	NULL
of	NULL
neutralizing	NULL
anti-	NULL
TGF-B	NULL
(	NULL
A	NULL
)	NULL
,	NULL
anti-	NULL
TNF-	NULL
Â«	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
anti-	NULL
TNFR55	NULL
(	NULL
C	NULL
)	NULL
antibodies	NULL
on	NULL
9-cis-RA-induced	NULL
growth	NULL
inhibition	NULL
of	NULL
BFU-E	NULL
colony	NULL
formation	NULL
by	NULL
CD34*	NULL
progenitor	NULL
cells	NULL
.	NULL

CD34*	NULL
cells	NULL
were	NULL
isolated	NULL
and	NULL
plated	NULL
in	NULL
methylcellulose	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
at	NULL
2	NULL
x	NULL
10Â°	NULL
cells/plate	NULL
supplemented	NULL
with	NULL
SCF	NULL
(	NULL
50	NULL
ng/mL	NULL
)	NULL
,	NULL
Epo	NULL
(	NULL
5	NULL
IU/mL	NULL
)	NULL
,	NULL
9-cis-RA	NULL
(	NULL
1	NULL
mol/L	NULL
[	NULL
A	NULL
]	NULL
or	NULL
10	NULL
nmol/L	NULL
[	NULL
B	NULL
and	NULL
CJ	NULL
)	NULL
,	NULL
TGF-B	NULL
.	NULL

(	NULL
0.2	NULL
ng/mL	NULL
}	NULL
,	NULL
TNF-a	NULL
(	NULL
20	NULL
ng/ml	NULL
}	NULL
,	NULL
neutralizing	NULL
antibody	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
,	NULL
neutralizing	NULL
anti-TNF-	NULL
Â«	NULL
antiserum	NULL
(	NULL
final	NULL
dilution	NULL
1:100	NULL
)	NULL
,	NULL
and	NULL
neutralizing	NULL
anti-TNFRS55	NULL
antibody	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
as	NULL
indicated	NULL
.	NULL

Cultures	NULL
were	NULL
scored	NULL
for	NULL
BFU-E	NULL
colony	NULL
formation	NULL
after	NULL
2	NULL
weeks	NULL
of	NULL
incubation	NULL
at	NULL
37Â°C	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
air	NULL
.	NULL

Results	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
absolute	NULL
number	NULL
of	NULL
colonies	NULL
formed	NULL
per	NULL
2	NULL
x	NULL
10Â°	NULL
cells	NULL
and	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
with	NULL
triplicate	NULL
determinations	NULL
;	NULL
error	NULL
bars	NULL
show	NULL
the	NULL
SEM	NULL
.	NULL

Irrelevant	NULL
control	NULL
antibodies	NULL
(	NULL
Materials	NULL
and	NULL
Methods	NULL
}	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
BFU-E	NULL
colony	NULL
formation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

*	NULL
,	NULL
No	NULL
colony	NULL
formation	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1732	NULL
Table	NULL
2	NULL
.	NULL

Induction	NULL
of	NULL
Transcription	NULL
in	NULL
P19	NULL
Cells	NULL
Relative	NULL
Transcriptional	NULL
Activity	NULL
Ligands	NULL
DR1	NULL
DRS	NULL
Medium	NULL
100	NULL
100	NULL
All-trans-RA	NULL
135	NULL
4,530	NULL
9-cis-RA	NULL
3,413	NULL
2,850	NULL
Ro	NULL
13-7410	NULL
{	NULL
TTNPB	NULL
)	NULL
140	NULL
5,450	NULL
Ro	NULL
25-6603	NULL
2,968	NULL
170	NULL
Ro	NULL
25-7386	NULL
3,292	NULL
200	NULL
P19	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
CRBP	NULL
(	NULL
I	NULL
}	NULL
}	NULL
)	NULL
-CAT	NULL
or	NULL
RARG2-LacZ	NULL
reporter	NULL
vectors	NULL
,	NULL
and	NULL
DR1-	NULL
and	NULL
DR5-driven	NULL
transcriptional	NULL
activities	NULL
were	NULL
determined	NULL
by	NULL
measuring	NULL
CAT	NULL
and	NULL
LacZ	NULL
reporter	NULL
enzyme	NULL
activi-ties	NULL
,	NULL
respectively	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

All	NULL
ligands	NULL
were	NULL
tested	NULL
at	NULL
100	NULL
nmol/L	NULL
.	NULL

The	NULL
results	NULL
are	NULL
given	NULL
as	NULL
relative	NULL
transcriptional	NULL
activity	NULL
normalized	NULL
to	NULL
the	NULL
value	NULL
of	NULL
the	NULL
medium	NULL
control	NULL
{	NULL
one	NULL
of	NULL
three	NULL
reproducible	NULL
experiments	NULL
)	NULL
.	NULL

RA-induced	NULL
inhibition	NULL
(	NULL
Fig	NULL
4C	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
neither	NULL
TGF-	NULL
$	NULL
8	NULL
nor	NULL
TNF-a	NULL
are	NULL
required	NULL
for	NULL
mediating	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
9-cis-RA	NULL
on	NULL
erythroid	NULL
progenitor	NULL
cell	NULL
growth	NULL
.	NULL

Involvement	NULL
of	NULL
RAR-RXR	NULL
and	NULL
RXR-RXR	NULL
response	NULL
pathways	NULL
in	NULL
mediating	NULL
RA-induced	NULL
effects	NULL
on	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
(	NULL
HPC	NULL
)	NULL
.	NULL

9-cis-RA	NULL
binds	NULL
to	NULL
both	NULL
RARs	NULL
and	NULL
RXRs	NULL
,	NULL
*	NULL
``	NULL
whereas	NULL
all-trans-RA	NULL
only	NULL
binds	NULL
to	NULL
RARs	NULL
.	NULL

*Â°	NULL
However	NULL
,	NULL
it	NULL
is	NULL
difficult	NULL
to	NULL
use	NULL
these	NULL
retinoids	NULL
in	NULL
studying	NULL
the	NULL
involvement	NULL
of	NULL
RAR-RXR	NULL
and	NULL
RXR-RXR	NULL
response	NULL
pathways	NULL
in	NULL
mediating	NULL
RA-induced	NULL
effects	NULL
on	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
,	NULL
because	NULL
all-trans-RA	NULL
as	NULL
well	NULL
as	NULL
9-cis-RA	NULL
partly	NULL
isomerize	NULL
in	NULL
culture	NULL
to	NULL
the	NULL
other	NULL
form	NULL
of	NULL
RA	NULL
(	NULL
R.	NULL
Blomhoff	NULL
et	NULL
al	NULL
,	NULL
unpublished	NULL
results	NULL
,	NULL
November	NULL
1993	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
no	NULL
natural	NULL
RXR-specific	NULL
ligands	NULL
have	NULL
been	NULL
identified	NULL
.	NULL

However	NULL
,	NULL
RA	NULL
analogues	NULL
have	NULL
been	NULL
synthesized	NULL
that	NULL
selectively	NULL
bind	NULL
to	NULL
RXRs	NULL
and	NULL
activate	NULL
the	NULL
RXR-RXR	NULL
pathway	NULL
,	NULL
but	NULL
not	NULL
the	NULL
RAR-RXR	NULL
pathway	NULL
.	NULL
``	NULL

So	NULL
,	NULL
to	NULL
dissect	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
two	NULL
retinoid	NULL
response	NULL
pathways	NULL
in	NULL
normal	NULL
hematopoietic	NULL
progenitor	NULL
cell	NULL
growth	NULL
,	NULL
we	NULL
took	NULL
advantage	NULL
of	NULL
synthetic	NULL
ligands	NULL
to	NULL
RARs	NULL
(	NULL
Ro	NULL
13-7410	NULL
)	NULL
and	NULL
RXRs	NULL
(	NULL
Ro	NULL
25-6603	NULL
and	NULL
Ro	NULL
25-7386	NULL
)	NULL
that	NULL
selectively	NULL
bind	NULL
and	NULL
activate	NULL
RAR-RXR	NULL
and	NULL
RXR-RXR	NULL
dimers	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
these	NULL
compounds	NULL
at	NULL
100	NULL
nmol/L	NULL
was	NULL
confirmed	NULL
in	NULL
transactivation	NULL
experiments	NULL
demonstrating	NULL
that	NULL
the	NULL
activities	NULL
of	NULL
Ro	NULL
13-7410	NULL
on	NULL
DR5-	NULL
and	NULL
DRI-regulated	NULL
transcription	NULL
were	NULL
5,450	NULL
and	NULL
140	NULL
,	NULL
respectively	NULL
,	NULL
compared	NULL
with	NULL
medium	NULL
controls	NULL
set	NULL
to	NULL
100	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
relative	NULL
activities	NULL
of	NULL
Ro	NULL
25-6603	NULL
on	NULL
DR1-	NULL
and	NULL
DR5-driven	NULL
transcription	NULL
were	NULL
2,968	NULL
and	NULL
170	NULL
,	NULL
respectively	NULL
,	NULL
whereas	NULL
the	NULL
relative	NULL
activities	NULL
of	NULL
Ro	NULL
25-7386	NULL
on	NULL
transcription	NULL
regulated	NULL
via	NULL
DR1	NULL
and	NULL
DRS	NULL
response	NULL
elements	NULL
were	NULL
3,292	NULL
and	NULL
200	NULL
,	NULL
respectively	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
transactivation	NULL
studies	NULL
we	NULL
next	NULL
investigated	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
selective	NULL
RAR	NULL
and	NULL
RXR	NULL
ligands	NULL
at	NULL
10	NULL
and	NULL
100	NULL
nmol/L	NULL
on	NULL
erythroid	NULL
colony	NULL
formation	NULL
of	NULL
CD34*	NULL
progenitor	NULL
cells	NULL
.	NULL

The	NULL
supplementation	NULL
of	NULL
all-trans-RA	NULL
and	NULL
the	NULL
RAR-selective	NULL
agonist	NULL
(	NULL
Ro	NULL
13-7410	NULL
)	NULL
inhibited	NULL
BFU-E	NULL
colony	NULL
formation	NULL
by	NULL
85	NULL
%	NULL
and	NULL
8Â§2	NULL
%	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
RXR-selective	NULL
agonists	NULL
Ro	NULL
25-6603	NULL
and	NULL
Ro	NULL
25-7386	NULL
also	NULL
significantly	NULL
inhibited	NULL
SCF	NULL
+	NULL
Epo-induced	NULL
BFU-E	NULL
colony	NULL
formation	NULL
at	NULL
both	NULL
10	NULL
and	NULL
100	NULL
nmol/L	NULL
.	NULL

Specifically	NULL
,	NULL
at	NULL
100	NULL
nmol/L	NULL
Ro	NULL
25-6603	NULL
and	NULL
Ro	NULL
25-7386	NULL
inhib-	NULL
RUSTEN	NULL
ET	NULL
AL	NULL
ited	NULL
BFU-E	NULL
colony	NULL
formation	NULL
by	NULL
75	NULL
%	NULL
(	NULL
P	NULL
<	NULL
.05	NULL
)	NULL
and	NULL
53	NULL
%	NULL
(	NULL
P	NULL
<	NULL
.05	NULL
)	NULL
,	NULL
whereas	NULL
at	NULL
10	NULL
nmol/L	NULL
the	NULL
inhibition	NULL
was	NULL
53	NULL
%	NULL
(	NULL
P	NULL
<	NULL
.05	NULL
)	NULL
and	NULL
31	NULL
%	NULL
(	NULL
P	NULL
<	NULL
.05	NULL
)	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

The	NULL
selective	NULL
RAR	NULL
agonist	NULL
Ro	NULL
13-7410	NULL
inhibited	NULL
SCF	NULL
+	NULL
Epo-induced	NULL
BFU-E	NULL
colony	NULL
formation	NULL
in	NULL
a	NULL
concentration-dependent	NULL
manner	NULL
,	NULL
with	NULL
ICs	NULL
,	NULL
observed	NULL
at	NULL
1	NULL
nmol/L	NULL
,	NULL
whereas	NULL
a	NULL
78	NULL
%	NULL
inhibition	NULL
was	NULL
observed	NULL
at	NULL
100	NULL
nmol/L	NULL
(	NULL
Fig	NULL
6A	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
a	NULL
selective	NULL
RXR	NULL
agonist	NULL
(	NULL
Ro	NULL
25-6603	NULL
)	NULL
inhibited	NULL
SCF	NULL
+	NULL
Epo-induced	NULL
BFU-E	NULL
colony	NULL
formation	NULL
in	NULL
a	NULL
concentration-dependent	NULL
manner	NULL
as	NULL
well	NULL
with	NULL
an	NULL
ICs	NULL
,	NULL
of	NULL
approximately	NULL
10	NULL
nmol/	NULL
L.	NULL
Seventy-one	NULL
percent	NULL
inhibition	NULL
was	NULL
observed	NULL
at	NULL
an	NULL
Ro	NULL
25-6603	NULL
concentration	NULL
of	NULL
100	NULL
nmol/L	NULL
(	NULL
Fig	NULL
6A	NULL
)	NULL
.	NULL

The	NULL
ICs	NULL
,	NULL
of	NULL
Ro	NULL
25-7386	NULL
was	NULL
approximately	NULL
100	NULL
nmol/L	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

In	NULL
a	NULL
recent	NULL
study	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
all-trans-RA	NULL
directly	NULL
inhibits	NULL
G-CSF-induced	NULL
colony	NULL
formation	NULL
of	NULL
CD34*	NULL
BM	NULL
progenitor	NULL
cells	NULL
.	NULL
``	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
all-trans-RA	NULL
inhibited	NULL
G-CSF-induced	NULL
colony	NULL
formation	NULL
in	NULL
a	NULL
concentration-dependent	NULL
manner	NULL
,	NULL
with	NULL
50	NULL
%	NULL
inhibition	NULL
occurring	NULL
at	NULL
an	NULL
all-trans-RA	NULL
concentration	NULL
of	NULL
10	NULL
to	NULL
100	NULL
nmol/L	NULL
,	NULL
whereas	NULL
a	NULL
62	NULL
%	NULL
inhibition	NULL
was	NULL
observed	NULL
at	NULL
100	NULL
nmol/L	NULL
(	NULL
Fig	NULL
6B	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
selective	NULL
RAR	NULL
agonist	NULL
Ro	NULL
13-7410	NULL
inhibited	NULL
G-CSF-induced	NULL
colony	NULL
growth	NULL
in	NULL
a	NULL
concentration-dependent	NULL
fash-ion	NULL
,	NULL
with	NULL
an	NULL
ICs	NULL
,	NULL
at	NULL
1	NULL
nmol/L	NULL
,	NULL
and	NULL
a	NULL
maximum	NULL
inhibition	NULL
of	NULL
63	NULL
%	NULL
was	NULL
observed	NULL
at	NULL
100	NULL
nmol/L	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
supplementation	NULL
of	NULL
the	NULL
selective	NULL
RXR	NULL
agonists	NULL
Ro	NULL
25-6603	NULL
and	NULL
Ro	NULL
25-7386	NULL
,	NULL
respectively	NULL
,	NULL
had	NULL
little	NULL
or	NULL
no	NULL
inhibitory	NULL
effect	NULL
at	NULL
concentrations	NULL
up	NULL
to	NULL
100	NULL
nmol/L	NULL
(	NULL
Fig	NULL
6B	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
concentration-responses	NULL
for	NULL
RAR	NULL
ligand-induced	NULL
growth	NULL
inhibition	NULL
of	NULL
BFU-E	NULL
and	NULL
myeloid	NULL
colony	NULL
formation	NULL
were	NULL
simi-lar	NULL
,	NULL
only	NULL
BFU-E	NULL
colony	NULL
growth	NULL
was	NULL
suppressed	NULL
by	NULL
the	NULL
RXR	NULL
selective	NULL
ligands	NULL
.	NULL

Thus	NULL
,	NULL
RA-induced	NULL
inhibition	NULL
of	NULL
G-CSF-	NULL
100	NULL
a	NULL
all-trans-RA	NULL
g	NULL
so4	NULL
T	NULL
E	NULL
22	NULL
2:22:32	NULL
8	NULL
0	NULL
co-	NULL
UTC	NULL
3	NULL
7	NULL
LL	NULL
8	NULL
=	NULL
20	NULL
0-	NULL
az	NULL
222	NULL
*	NULL
0	NULL
_	NULL
100	NULL
10	NULL
10	NULL
100	NULL
1	NULL
O	NULL
_s	NULL
el	NULL
O	NULL
Retinoids	NULL
,	NULL
nM	NULL
Fig	NULL
5	NULL
.	NULL

Effects	NULL
of	NULL
receptor-selective	NULL
retinoids	NULL
on	NULL
SCF	NULL
+	NULL
Epo-induced	NULL
erythroid	NULL
colony	NULL
formation	NULL
of	NULL
BM	NULL
progenitor	NULL
cells	NULL
.	NULL

CD34*	NULL
human	NULL
BM	NULL
cells	NULL
were	NULL
separated	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
and	NULL
cultured	NULL
at	NULL
2	NULL
x	NULL
10Â°	NULL
cells/plate	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
predetermined	NULL
optimal	NULL
concentration	NULL
of	NULL
SCF	NULL
+	NULL
Epo	NULL
and	NULL
selected	NULL
concentrations	NULL
of	NULL
retinoids	NULL
as	NULL
indicated	NULL
.	NULL

Cultures	NULL
were	NULL
scored	NULL
for	NULL
BFU-E	NULL
colony	NULL
formation	NULL
after	NULL
2	NULL
weeks	NULL
of	NULL
incubation	NULL
at	NULL
37Â°C	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
air	NULL
.	NULL

Results	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
absolute	NULL
number	NULL
of	NULL
BFU-E	NULL
colonies	NULL
formed	NULL
and	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
with	NULL
duplicate	NULL
determinations	NULL
;	NULL
error	NULL
bars	NULL
show	NULL
the	NULL
SEM	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

RETINOIDS	NULL
INHIBIT	NULL
ERYTHROPOIESIS	NULL
stimulated	NULL
colony	NULL
formation	NULL
appears	NULL
to	NULL
be	NULL
exclusively	NULL
mediated	NULL
through	NULL
activation	NULL
of	NULL
the	NULL
RAR-RXR	NULL
response	NULL
pathway	NULL
,	NULL
whereas	NULL
selective	NULL
activation	NULL
of	NULL
the	NULL
RAR-RXR	NULL
as	NULL
well	NULL
as	NULL
the	NULL
RXR-RXR	NULL
pathway	NULL
can	NULL
signal	NULL
imbibition	NULL
of	NULL
BFU-E	NULL
colony	NULL
formation	NULL
.	NULL

A	NULL
100	NULL
7	NULL
@	NULL
-	NULL
807	NULL
{	NULL
g	NULL
}	NULL
2	NULL
|	NULL
9	NULL
g	NULL
-	NULL
607	NULL
Lu	NULL
P	NULL
P	NULL
-	NULL
404	NULL
oo	NULL
|	NULL
0	NULL
o-	NULL
207	NULL
o	NULL
22	NULL
.	NULL

0	NULL
2	NULL
_	NULL
54k	NULL
y	NULL
T	NULL
T	NULL
I	NULL
U	NULL
L	NULL
102	NULL
10	NULL
}	NULL
100	NULL
101	NULL
102	NULL
Retinoids	NULL
,	NULL
nM	NULL
J	NULL
No	NULL
.	NULL

of	NULL
CFU-GM	NULL
colonies	NULL
0	NULL
2	NULL
_	NULL
r	NULL
--	NULL
T	NULL
T	NULL
T	NULL
7	NULL
0	NULL
102	NULL
101	NULL
100	NULL
10	NULL
102	NULL
Retinoids	NULL
,	NULL
nM	NULL
Fig	NULL
6	NULL
.	NULL

Concentration-response	NULL
of	NULL
receptor-selective	NULL
retinoid-in-duced	NULL
inhibition	NULL
of	NULL
SCF	NULL
+	NULL
Epo-stimulated	NULL
erythroid	NULL
colony	NULL
formation	NULL
and	NULL
G-CSF-induced	NULL
CFU-GM	NULL
colony	NULL
formation	NULL
.	NULL

CD34*	NULL
human	NULL
BM	NULL
cells	NULL
were	NULL
separated	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
and	NULL
cultured	NULL
at	NULL
2	NULL
x	NULL
10Â°	NULL
cells/plate	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
predetermined	NULL
optimal	NULL
concentrations	NULL
of	NULL
(	NULL
A	NULL
)	NULL
SCF	NULL
+	NULL
Epo	NULL
,	NULL
and	NULL
increasing	NULL
concentrations	NULL
of	NULL
Ro	NULL
13-7410	NULL
(	NULL
M	NULL
}	NULL
and	NULL
Ro	NULL
25-6603	NULL
(	NULL
A	NULL
}	NULL
,	NULL
or	NULL
(	NULL
B	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
predetermined	NULL
optimal	NULL
concentration	NULL
of	NULL
G-CSF	NULL
,	NULL
and	NULL
increasing	NULL
concentrations	NULL
of	NULL
all-trans-RA	NULL
(	NULL
0	NULL
)	NULL
,	NULL
Ro	NULL
13-7410	NULL
(	NULL
A	NULL
)	NULL
,	NULL
Ro	NULL
25-6603	NULL
(	NULL
A	NULL
}	NULL
,	NULL
and	NULL
Ro	NULL
25-7386	NULL
{	NULL
D	NULL
}	NULL
.	NULL

Cultures	NULL
were	NULL
scored	NULL
for	NULL
{	NULL
A	NULL
)	NULL
absolute	NULL
number	NULL
of	NULL
BFU-E	NULL
colonies	NULL
after	NULL
14	NULL
days	NULL
of	NULL
incubation	NULL
,	NULL
or	NULL
(	NULL
B	NULL
)	NULL
G-CSF-induced	NULL
CFU-GM	NULL
colony	NULL
growth	NULL
after	NULL
1	NULL
week	NULL
of	NULL
incubation	NULL
at	NULL
37Â°C	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
air	NULL
.	NULL

Results	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
with	NULL
duplicate	NULL
determinations	NULL
.	NULL

1733	NULL
Table	NULL
3	NULL
.	NULL

Effects	NULL
of	NULL
Retinoids	NULL
on	NULL
SCF	NULL
+	NULL
Epo-Induced	NULL
BFU-E	NULL
Colony	NULL
Formation	NULL
of	NULL
CD34*	NULL
BM	NULL
Cells	NULL
in	NULL
Serum-Deprived	NULL
Medium	NULL
No	NULL
.	NULL

of	NULL
BFU-E	NULL
Colonies	NULL
Epo	NULL
+	NULL
SCF	NULL
42	NULL
(	NULL
6	NULL
)	NULL
+all-trans-RA	NULL
22	NULL
(	NULL
3	NULL
)	NULL
+9-cis-RA	NULL
21	NULL
(	NULL
3	NULL
)	NULL
+Ro	NULL
13-7410	NULL
19	NULL
(	NULL
3	NULL
)	NULL
+Ro	NULL
25-6603	NULL
27	NULL
(	NULL
4	NULL
)	NULL
CD34*	NULL
cells	NULL
were	NULL
plated	NULL
in	NULL
1	NULL
mL	NULL
serum-deprived	NULL
methylcellulose	NULL
medium	NULL
(	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
14	NULL
days	NULL
at	NULL
37Â°C	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
air	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
predetermined	NULL
optimal	NULL
concentrations	NULL
of	NULL
SCF	NULL
and	NULL
Epo	NULL
,	NULL
and	NULL
the	NULL
retinoids	NULL
indicated	NULL
at	NULL
100	NULL
nmol/L	NULL
(	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Results	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
mean	NULL
number	NULL
of	NULL
colonies	NULL
per	NULL
2	NULL
x	NULL
10Â°	NULL
cells	NULL
(	NULL
SEM	NULL
)	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
with	NULL
duplicate	NULL
determinations	NULL
.	NULL

Next	NULL
,	NULL
experiments	NULL
were	NULL
performed	NULL
to	NULL
investigate	NULL
whether	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
retinoids	NULL
required	NULL
the	NULL
presence	NULL
of	NULL
serum	NULL
.	NULL

In	NULL
serum-deprived	NULL
cultures	NULL
,	NULL
all-trans-RA	NULL
and	NULL
9-cisRA	NULL
(	NULL
100	NULL
nmol/L	NULL
)	NULL
inhibited	NULL
SCF	NULL
+	NULL
Epo-induced	NULL
BFU-E	NULL
colony	NULL
formation	NULL
by	NULL
48	NULL
%	NULL
and	NULL
51	NULL
%	NULL
,	NULL
respectively	NULL
(	NULL
Table	NULL
3	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
receptor-selective	NULL
retinoids	NULL
Ro	NULL
13-7410	NULL
and	NULL
Ro	NULL
25-6603	NULL
inhibited	NULL
BFU-E	NULL
colony	NULL
growth	NULL
by	NULL
54	NULL
%	NULL
(	NULL
P	NULL
<	NULL
.05	NULL
)	NULL
and	NULL
36	NULL
%	NULL
(	NULL
P	NULL
<	NULL
.05	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
reti-noid-induced	NULL
inhibition	NULL
of	NULL
BFU-E	NULL
colony	NULL
formation	NULL
appeared	NULL
less	NULL
pronounced	NULL
in	NULL
serum-deprived	NULL
than	NULL
serum-con-taining	NULL
medium	NULL
,	NULL
the	NULL
results	NULL
confirmed	NULL
the	NULL
involvement	NULL
of	NULL
both	NULL
the	NULL
RAR-RXR	NULL
and	NULL
RXR-RXR	NULL
pathways	NULL
.	NULL

DISCUSSION	NULL
Previous	NULL
studies	NULL
on	NULL
in	NULL
vitro	NULL
effects	NULL
of	NULL
retinoids	NULL
on	NULL
erythropoiesis	NULL
have	NULL
revealed	NULL
contrasting	NULL
results	NULL
,	NULL
ranging	NULL
from	NULL
inhi-bition	NULL
``	NULL
*	NULL
``	NULL
*	NULL
to	NULL
potent	NULL
enhancement	NULL
of	NULL
erythroid	NULL
progenitor	NULL
cell	NULL
growth	NULL
.	NULL
``	NULL

''	NULL
The	NULL
present	NULL
study	NULL
,	NULL
using	NULL
highly	NULL
enriched	NULL
human	NULL
CD34*	NULL
BM	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
Lin~	NULL
murine	NULL
BM	NULL
progenitors	NULL
,	NULL
shows	NULL
a	NULL
potent	NULL
concentration-dependent	NULL
inhibitory	NULL
effect	NULL
of	NULL
RA	NULL
on	NULL
BFU-E	NULL
colony	NULL
formation	NULL
in	NULL
response	NULL
to	NULL
multiple	NULL
cytokine	NULL
combinations	NULL
.	NULL

Erythroid	NULL
colony	NULL
growth	NULL
was	NULL
also	NULL
inhibited	NULL
in	NULL
single-cell	NULL
cloning	NULL
experiments	NULL
,	NULL
suggesting	NULL
a	NULL
direct	NULL
action	NULL
of	NULL
RA	NULL
on	NULL
the	NULL
progenitor	NULL
cells	NULL
.	NULL

Others	NULL
have	NULL
found	NULL
the	NULL
plasma	NULL
levels	NULL
of	NULL
RA	NULL
isoforms	NULL
in	NULL
humans	NULL
to	NULL
be	NULL
approximately	NULL
10	NULL
nmol/L	NULL
.	NULL
``	NULL

However	NULL
,	NULL
the	NULL
in	NULL
vivo	NULL
relevance	NULL
of	NULL
the	NULL
higher	NULL
concentrations	NULL
of	NULL
RA	NULL
used	NULL
in	NULL
this	NULL
study	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

It	NULL
is	NULL
noteworthy	NULL
that	NULL
stimulatory	NULL
effects	NULL
of	NULL
RA	NULL
on	NULL
erythroid	NULL
progenitor	NULL
cell	NULL
growth	NULL
have	NULL
been	NULL
found	NULL
only	NULL
in	NULL
studies	NULL
using	NULL
unpurified	NULL
erythroid	NULL
progenitors	NULL
,	NULL
``	NULL
suggesting	NULL
the	NULL
possible	NULL
involvement	NULL
of	NULL
indirect	NULL
effects	NULL
of	NULL
RA	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
only	NULL
one	NULL
recent	NULL
study	NULL
has	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
RA	NULL
on	NULL
BFU-E	NULL
colony	NULL
formation	NULL
in	NULL
purified	NULL
CD34*	NULL
BM	NULL
cells	NULL
,	NULL
but	NULL
in	NULL
this	NULL
study	NULL
it	NULL
was	NULL
not	NULL
shown	NULL
whether	NULL
the	NULL
observed	NULL
inhibitory	NULL
effect	NULL
of	NULL
RA	NULL
was	NULL
directly	NULL
mediated	NULL
.	NULL
``	NULL

Furthermore	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
RA	NULL
on	NULL
erythroid	NULL
progenitors	NULL
might	NULL
vary	NULL
with	NULL
their	NULL
maturation	NULL
stage	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
Labbaye	NULL
et	NULL
al	NULL
``	NULL
``	NULL
demonstrated	NULL
an	NULL
inhibitory	NULL
effect	NULL
of	NULL
all-trams-RA	NULL
on	NULL
purified	NULL
peripheral	NULL
blood	NULL
erythroid	NULL
progenitors	NULL
when	NULL
added	NULL
at	NULL
day	NULL
0	NULL
,	NULL
whereas	NULL
the	NULL
delayed	NULL
supplementation	NULL
of	NULL
all-trans-RA	NULL
(	NULL
day	NULL
8	NULL
)	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
proliferation	NULL
,	NULL
indicating	NULL
a	NULL
predominant	NULL
action	NULL
of	NULL
RA	NULL
on	NULL
early	NULL
erythroid	NULL
progenitors	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1734	NULL
Whereas	NULL
it	NULL
is	NULL
now	NULL
established	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
RA	NULL
(	NULL
stimulatory	NULL
or	NULL
inhibitory	NULL
)	NULL
on	NULL
GM	NULL
progenitors	NULL
are	NULL
in	NULL
part	NULL
dependent	NULL
on	NULL
the	NULL
specific	NULL
growth	NULL
factors	NULL
it	NULL
interacts	NULL
with	NULL
,	NULL
``	NULL
``	NULL
no	NULL
previous	NULL
studies	NULL
have	NULL
examined	NULL
whether	NULL
RA	NULL
differentially	NULL
affects	NULL
erythroid	NULL
colony	NULL
formation	NULL
induced	NULL
by	NULL
different	NULL
cyto-kines	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
BFU-E	NULL
colony	NULL
formation	NULL
in	NULL
response	NULL
to	NULL
Epo	NULL
,	NULL
Epo	NULL
+	NULL
SCF	NULL
,	NULL
Epo	NULL
+	NULL
IL-3	NULL
,	NULL
Epo	NULL
+	NULL
IL-4	NULL
,	NULL
and	NULL
Epo	NULL
+	NULL
IL-9	NULL
is	NULL
potently	NULL
inhibited	NULL
by	NULL
RA	NULL
.	NULL

Thus	NULL
,	NULL
unlike	NULL
its	NULL
effects	NULL
on	NULL
GM	NULL
progenitors	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
RA	NULL
on	NULL
erythroid	NULL
progenitors	NULL
appears	NULL
to	NULL
be	NULL
solely	NULL
inhibitory	NULL
and	NULL
independent	NULL
of	NULL
the	NULL
cooperating	NULL
cytokines	NULL
stimulating	NULL
growth	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
to	NULL
be	NULL
noted	NULL
that	NULL
RA-induced	NULL
inhibition	NULL
can	NULL
be	NULL
counteracted	NULL
by	NULL
the	NULL
combined	NULL
action	NULL
of	NULL
multiple	NULL
erythroid	NULL
stimuli	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
~100-fold	NULL
difference	NULL
in	NULL
the	NULL
ED	NULL
;	NULL
,	NULL
for	NULL
RA	NULL
when	NULL
combined	NULL
with	NULL
SCF	NULL
+	NULL
Epo	NULL
versus	NULL
SCF	NULL
+	NULL
IL-3	NULL
+	NULL
IL-9	NULL
+	NULL
Epo	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
notion	NULL
that	NULL
multiple	NULL
stimulatory	NULL
growth	NULL
factors	NULL
can	NULL
cooperate	NULL
to	NULL
overcome	NULL
the	NULL
inhibition	NULL
by	NULL
negative	NULL
regulators	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
it	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
combined	NULL
actions	NULL
of	NULL
multiple	NULL
cytokines	NULL
can	NULL
oppose	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
and	NULL
TNF-	NULL
61.45.48	NULL
It	NULL
has	NULL
previously	NULL
been	NULL
reported	NULL
that	NULL
human	NULL
CD34	NULL
*	NULL
progenitor	NULL
cells	NULL
can	NULL
produce	NULL
TGF-	NULL
$	NULL
;	NULL
,	NULL
*	NULL
and	NULL
that	NULL
RA	NULL
can	NULL
induce	NULL
TGF-8	NULL
,	NULL
protein	NULL
production	NULL
in	NULL
a	NULL
human	NULL
myeloid	NULL
leukemia	NULL
cell	NULL
line	NULL
(	NULL
HL-60	NULL
)	NULL
.	NULL

*	NULL
``	NULL
However	NULL
,	NULL
the	NULL
present	NULL
study	NULL
suggests	NULL
that	NULL
a	NULL
TGF-Â§8	NULL
autocrine	NULL
loop	NULL
is	NULL
not	NULL
required	NULL
for	NULL
mediating	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
RA	NULL
on	NULL
BFU-E	NULL
colony	NULL
formation	NULL
,	NULL
because	NULL
the	NULL
supplementation	NULL
of	NULL
a	NULL
neutralizing	NULL
antibody	NULL
had	NULL
little	NULL
or	NULL
no	NULL
effect	NULL
on	NULL
9-cis-RA-induced	NULL
inhibition	NULL
.	NULL

Furthermore	NULL
,	NULL
although	NULL
RA-induced	NULL
effects	NULL
on	NULL
myelopoiesis	NULL
partly	NULL
mimic	NULL
those	NULL
of	NULL
TNF-a	NULL
@	NULL
,	NULL
the	NULL
supplementation	NULL
of	NULL
a	NULL
neutralizing	NULL
anti-	NULL
antiserum	NULL
did	NULL
not	NULL
affect	NULL
RA-induced	NULL
inhibition	NULL
of	NULL
BFU-E	NULL
colony	NULL
growth	NULL
,	NULL
suggesting	NULL
that	NULL
TNF-	NULL
Â«	NULL
is	NULL
not	NULL
involved	NULL
in	NULL
mediating	NULL
RA	NULL
effects	NULL
on	NULL
erythroid	NULL
colony	NULL
formation	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
demonstrated	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
TNF-a	NULL
on	NULL
committed	NULL
BM	NULL
progenitor	NULL
cells	NULL
are	NULL
almost	NULL
exclusively	NULL
mediated	NULL
by	NULL
TNFR55	NULL
,	NULL
****Â°	NULL
and	NULL
the	NULL
present	NULL
results	NULL
show	NULL
that	NULL
activation	NULL
of	NULL
TNFR55	NULL
is	NULL
not	NULL
required	NULL
for	NULL
the	NULL
observed	NULL
RA-induced	NULL
inhibition	NULL
of	NULL
BFU-E	NULL
colony	NULL
formation	NULL
.	NULL

Anemia	NULL
has	NULL
been	NULL
ascribed	NULL
to	NULL
both	NULL
vitamin	NULL
A	NULL
deficiency	NULL
'*	NULL
``	NULL
and	NULL
hypervitaminosis	NULL
A	NULL
.	NULL
``	NULL

One	NULL
might	NULL
speculate	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
present	NULL
study	NULL
,	NULL
that	NULL
the	NULL
anemia	NULL
related	NULL
to	NULL
the	NULL
latter	NULL
might	NULL
at	NULL
least	NULL
in	NULL
part	NULL
be	NULL
a	NULL
result	NULL
of	NULL
a	NULL
direct	NULL
inhibitory	NULL
action	NULL
of	NULL
RA	NULL
on	NULL
the	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
,	NULL
although	NULL
it	NULL
might	NULL
also	NULL
indirectly	NULL
result	NULL
from	NULL
the	NULL
multiple	NULL
abnormalities	NULL
associated	NULL
with	NULL
hypervitaminosis	NULL
A	NULL
,	NULL
including	NULL
impaired	NULL
liver	NULL
func-tion	NULL
.	NULL

Similarly	NULL
,	NULL
indirect	NULL
mechanisms	NULL
may	NULL
account	NULL
for	NULL
the	NULL
anemia	NULL
associated	NULL
with	NULL
vitamin	NULL
A	NULL
deficiency	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
,	NULL
vitamin	NULL
A	NULL
deficiency	NULL
in	NULL
mice	NULL
results	NULL
in	NULL
overproduction	NULL
of	NULL
interferon-y	NULL
,	NULL
``	NULL
'	NULL
a	NULL
known	NULL
inhibitor	NULL
of	NULL
erythroid	NULL
progenitor	NULL
growth	NULL
,	NULL
``	NULL
``	NULL
which	NULL
can	NULL
be	NULL
corrected	NULL
by	NULL
vitamin	NULL
A	NULL
supplementa-tion	NULL
.	NULL

Furthermore	NULL
,	NULL
vitamin	NULL
A	NULL
deficiency	NULL
is	NULL
associated	NULL
with	NULL
altered	NULL
iron	NULL
metabolism	NULL
,	NULL
which	NULL
can	NULL
contribute	NULL
to	NULL
the	NULL
development	NULL
of	NULL
anemia	NULL
.	NULL
'	NULL

''	NULL
``	NULL
``	NULL
``	NULL
``	NULL
Thus	NULL
,	NULL
although	NULL
the	NULL
present	NULL
study	NULL
suggests	NULL
that	NULL
RA	NULL
can	NULL
directly	NULL
inhibit	NULL
the	NULL
growth	NULL
of	NULL
erythroid	NULL
progenitors	NULL
,	NULL
it	NULL
seems	NULL
likely	NULL
that	NULL
RA	NULL
,	NULL
presumably	NULL
by	NULL
indirect	NULL
mechanisms	NULL
,	NULL
might	NULL
be	NULL
required	NULL
for	NULL
normal	NULL
erythroid	NULL
devel-opment	NULL
.	NULL

Using	NULL
synthetic	NULL
retinoids	NULL
selective	NULL
for	NULL
either	NULL
of	NULL
the	NULL
two	NULL
retinoid	NULL
response	NULL
pathways	NULL
,	NULL
Dawson	NULL
et	NULL
al	NULL
``	NULL
``	NULL
recently	NULL
showed	NULL
RUSTEN	NULL
ET	NULL
AL	NULL
that	NULL
the	NULL
differentiating	NULL
and	NULL
antiproliferative	NULL
effects	NULL
of	NULL
retinoids	NULL
on	NULL
myeloid	NULL
cell	NULL
lines	NULL
are	NULL
mainly	NULL
mediated	NULL
through	NULL
RAR-RXR	NULL
heterodimers	NULL
,	NULL
and	NULL
not	NULL
RXR-RXR	NULL
homodimers	NULL
.	NULL

Using	NULL
retinoids	NULL
with	NULL
a	NULL
high	NULL
degree	NULL
of	NULL
receptor	NULL
selectivity	NULL
,	NULL
the	NULL
present	NULL
study	NULL
suggests	NULL
that	NULL
the	NULL
RAR-RXR	NULL
response	NULL
pathway	NULL
can	NULL
signal	NULL
inhibition	NULL
of	NULL
SCF	NULL
+	NULL
Epo-stimulated	NULL
erythroid	NULL
colony	NULL
growth	NULL
,	NULL
as	NULL
well	NULL
as	NULL
inhibition	NULL
of	NULL
G-CSF-stimulated	NULL
myeloid	NULL
colony	NULL
formation	NULL
.	NULL

Interestingly	NULL
,	NULL
two	NULL
different	NULL
RXR-selective	NULL
ligands	NULL
signaled	NULL
growth	NULL
inhibition	NULL
of	NULL
SCF	NULL
+	NULL
Epo-stimulated	NULL
erythroid	NULL
but	NULL
not	NULL
G-CSF-stimulated	NULL
myeloid	NULL
colony	NULL
formation	NULL
.	NULL

This	NULL
conclusion	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
100	NULL
nmoVL	NULL
as	NULL
well	NULL
as	NULL
10	NULL
nmol/L	NULL
of	NULL
the	NULL
RXR-selective	NULL
ligands	NULL
resulted	NULL
in	NULL
potent	NULL
inhibition	NULL
of	NULL
BFU-E	NULL
colony	NULL
formation	NULL
while	NULL
having	NULL
little	NULL
or	NULL
no	NULL
effect	NULL
on	NULL
G-CSF-induced	NULL
progenitor	NULL
cell	NULL
growth	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
IC	NULL
;	NULL
,	NULL
for	NULL
the	NULL
inhibition	NULL
induced	NULL
by	NULL
the	NULL
RAR-selective	NULL
ligand	NULL
was	NULL
similar	NULL
for	NULL
the	NULL
erythroid	NULL
and	NULL
myeloid	NULL
colony	NULL
formation	NULL
.	NULL

RXR-RXR	NULL
homodimers	NULL
have	NULL
response	NULL
elements	NULL
different	NULL
from	NULL
RAR-RXR	NULL
heterodimers	NULL
,	NULL
``	NULL
suggesting	NULL
they	NULL
activate	NULL
distinct	NULL
sets	NULL
of	NULL
genes	NULL
.	NULL

Accordingly	NULL
,	NULL
the	NULL
reason	NULL
why	NULL
RXR	NULL
specific	NULL
ligands	NULL
might	NULL
selectively	NULL
inhibit	NULL
erythroid	NULL
but	NULL
not	NULL
myeloid	NULL
progenitor	NULL
cell	NULL
growth	NULL
might	NULL
be	NULL
that	NULL
they	NULL
activate	NULL
pathways	NULL
inhibiting	NULL
erythroid	NULL
but	NULL
not	NULL
myeloid	NULL
differentia-tion	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
present	NULL
study	NULL
might	NULL
suggest	NULL
a	NULL
differential	NULL
activation	NULL
of	NULL
the	NULL
RXR-RXR	NULL
pathway	NULL
in	NULL
erythroid	NULL
and	NULL
G-CSF-responsive	NULL
myeloid	NULL
progenitor	NULL
cells	NULL
.	NULL

This	NULL
could	NULL
be	NULL
due	NULL
to	NULL
the	NULL
fact	NULL
that	NULL
RXR	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
form	NULL
heterodimers	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
nuclear	NULL
receptors	NULL
.	NULL
``	NULL

These	NULL
heterodimers	NULL
can	NULL
compete	NULL
with	NULL
RAR-RXR	NULL
heterodimers	NULL
and	NULL
RXR-RXR	NULL
homodimers	NULL
and	NULL
modulate	NULL
the	NULL
expression	NULL
of	NULL
genes	NULL
driven	NULL
by	NULL
RA	NULL
response	NULL
elements	NULL
or	NULL
retinoid	NULL
X	NULL
response	NULL
ele-ments	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
the	NULL
availability	NULL
of	NULL
such	NULL
nuclear	NULL
receptors	NULL
might	NULL
provide	NULL
a	NULL
regulatory	NULL
mechanism	NULL
that	NULL
at	NULL
least	NULL
in	NULL
part	NULL
could	NULL
explain	NULL
the	NULL
observed	NULL
differences	NULL
between	NULL
the	NULL
two	NULL
cell	NULL
types	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
both	NULL
RAR-RXR	NULL
and	NULL
RXR-RXR	NULL
response	NULL
pathways	NULL
appear	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
mediating	NULL
effects	NULL
of	NULL
retinoids	NULL
on	NULL
hematopoietic	NULL
cells	NULL
.	NULL

The	NULL
involvement	NULL
of	NULL
the	NULL
RXR-RXR	NULL
pathway	NULL
in	NULL
signaling	NULL
inhibitory	NULL
effects	NULL
on	NULL
erythroid	NULL
progenitors	NULL
is	NULL
of	NULL
particular	NULL
interest	NULL
because	NULL
,	NULL
to	NULL
our	NULL
knowl-edge	NULL
,	NULL
this	NULL
is	NULL
the	NULL
first	NULL
reported	NULL
biologic	NULL
response	NULL
elicited	NULL
by	NULL
selective	NULL
activation	NULL
of	NULL
this	NULL
pathway	NULL
.	NULL

ACKNOWLEDGMENT	NULL
The	NULL
authors	NULL
are	NULL
grateful	NULL
to	NULL
Cecilie	NULL
Okkenhaug	NULL
,	NULL
June	NULL
Helen	NULL
Myklebust	NULL
,	NULL
and	NULL
Grete	NULL
Okern	NULL
for	NULL
expert	NULL
technical	NULL
assistance	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Maden	NULL
M	NULL
:	NULL
Role	NULL
of	NULL
retinoids	NULL
in	NULL
embryonic	NULL
development	NULL
,	NULL
in	NULL
Blomhoff	NULL
R	NULL
(	NULL
ed	NULL
)	NULL
:	NULL
Vitamin	NULL
A	NULL
in	NULL
Health	NULL
and	NULL
Disease	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Dekker	NULL
,	NULL
1994	NULL
,	NULL
p	NULL
289	NULL
2	NULL
.	NULL

Blomhoff	NULL
HK	NULL
,	NULL
Smeland	NULL
EB	NULL
:	NULL
Role	NULL
of	NULL
retinoids	NULL
in	NULL
normal	NULL
hematopoiesis	NULL
and	NULL
the	NULL
immune	NULL
system	NULL
,	NULL
in	NULL
Blomhoff	NULL
R	NULL
(	NULL
ed	NULL
)	NULL
:	NULL
Vitamin	NULL
A	NULL
in	NULL
Health	NULL
and	NULL
Disease	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Dekker	NULL
,	NULL
1994	NULL
,	NULL
p	NULL
451	NULL
3	NULL
.	NULL

Blomhoff	NULL
R	NULL
,	NULL
Green	NULL
MH	NULL
,	NULL
Berg	NULL
T	NULL
,	NULL
Norum	NULL
KR	NULL
:	NULL
Transport	NULL
and	NULL
storage	NULL
of	NULL
vitamin	NULL
A	NULL
.	NULL

Science	NULL
250:399	NULL
,	NULL
1990	NULL
4	NULL
.	NULL

Petkovich	NULL
M	NULL
,	NULL
Brand	NULL
NJ	NULL
,	NULL
Krust	NULL
A	NULL
,	NULL
Chambon	NULL
P	NULL
:	NULL
A	NULL
human	NULL
retinoic	NULL
acid	NULL
receptor	NULL
which	NULL
belongs	NULL
to	NULL
the	NULL
family	NULL
of	NULL
nuclear	NULL
receptors	NULL
.	NULL

Nature	NULL
330:444	NULL
,	NULL
1987	NULL
5	NULL
.	NULL

Giguere	NULL
V	NULL
,	NULL
Ong	NULL
ES	NULL
,	NULL
Segui	NULL
P	NULL
,	NULL
Evans	NULL
RM	NULL
:	NULL
Identification	NULL
of	NULL
a	NULL
receptor	NULL
for	NULL
the	NULL
morphogen	NULL
retinoic	NULL
acid	NULL
.	NULL

Nature	NULL
330:624	NULL
,	NULL
1987	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

RETINOIDS	NULL
INHIBIT	NULL
ERYTHROPOIESIS	NULL
6	NULL
.	NULL

Mangelsdorf	NULL
DJ	NULL
,	NULL
Ong	NULL
ES	NULL
,	NULL
Dyck	NULL
JA	NULL
,	NULL
Evans	NULL
RM	NULL
:	NULL
Nuclear	NULL
receptor	NULL
that	NULL
identifies	NULL
a	NULL
novel	NULL
retinoic	NULL
acid	NULL
response	NULL
pathway	NULL
.	NULL

Nature	NULL
345:224	NULL
,	NULL
1990	NULL
7	NULL
.	NULL

Yu	NULL
VC	NULL
,	NULL
Delsert	NULL
C	NULL
,	NULL
Andersen	NULL
B	NULL
,	NULL
Holloway	NULL
JM	NULL
,	NULL
Devary	NULL
OV	NULL
,	NULL
Niir	NULL
AM	NULL
,	NULL
Kim	NULL
SY	NULL
,	NULL
Boutin	NULL
J-M	NULL
,	NULL
Glass	NULL
CK	NULL
,	NULL
Rosenfeld	NULL
MG	NULL
:	NULL
RXR	NULL
:	NULL
A	NULL
coregulator	NULL
that	NULL
enhances	NULL
binding	NULL
of	NULL
retinoic	NULL
acid	NULL
,	NULL
thyroid	NULL
hormone	NULL
,	NULL
and	NULL
vitamin	NULL
D	NULL
receptors	NULL
to	NULL
their	NULL
cognate	NULL
response	NULL
elements	NULL
.	NULL

Cell	NULL
67:1251	NULL
,	NULL
1991	NULL
8	NULL
.	NULL

Zhang	NULL
X-k	NULL
,	NULL
Hoffmann	NULL
B	NULL
,	NULL
Tran	NULL
PB-V	NULL
,	NULL
Graupner	NULL
G	NULL
,	NULL
Pfahl	NULL
M	NULL
:	NULL
Retinoid	NULL
X	NULL
receptor	NULL
is	NULL
an	NULL
auxiliary	NULL
protein	NULL
for	NULL
thyroid	NULL
hormone	NULL
and	NULL
retinoic	NULL
acid	NULL
receptors	NULL
.	NULL

Nature	NULL
355:441	NULL
,	NULL
1992	NULL
9	NULL
.	NULL

Leid	NULL
M	NULL
,	NULL
Kastner	NULL
P	NULL
,	NULL
Lyons	NULL
R	NULL
,	NULL
Nakshatri	NULL
H	NULL
,	NULL
Saunders	NULL
M	NULL
,	NULL
Zacha-rewski	NULL
T	NULL
,	NULL
Chen	NULL
J-Y	NULL
,	NULL
Staub	NULL
A	NULL
,	NULL
Garnier	NULL
J-M	NULL
,	NULL
Mader	NULL
S	NULL
,	NULL
Chambon	NULL
P	NULL
:	NULL
Purification	NULL
,	NULL
cloning	NULL
,	NULL
and	NULL
RXR	NULL
identity	NULL
of	NULL
the	NULL
HeLa	NULL
cell	NULL
factor	NULL
with	NULL
which	NULL
RAR	NULL
or	NULL
TR	NULL
heterodimerizes	NULL
to	NULL
bind	NULL
target	NULL
sequences	NULL
effi-ciently	NULL
.	NULL

Cell	NULL
68:377	NULL
,	NULL
1992	NULL
10	NULL
.	NULL

Kliewer	NULL
SA	NULL
,	NULL
Umesono	NULL
K	NULL
,	NULL
Mangelsdorf	NULL
DJ	NULL
,	NULL
Evans	NULL
RM	NULL
:	NULL
Retinoid	NULL
X	NULL
receptor	NULL
interacts	NULL
with	NULL
nuclear	NULL
receptors	NULL
in	NULL
retinoic	NULL
acid	NULL
,	NULL
thyroid	NULL
hormone	NULL
and	NULL
vitamin	NULL
D3	NULL
signalling	NULL
.	NULL

Nature	NULL
355:446	NULL
,	NULL
1992	NULL
11	NULL
.	NULL

Bugge	NULL
TH	NULL
,	NULL
Pohl	NULL
J	NULL
,	NULL
Lonnoy	NULL
O	NULL
,	NULL
Stunnenberg	NULL
HG	NULL
:	NULL
RXRa	NULL
,	NULL
a	NULL
promiscuous	NULL
partner	NULL
of	NULL
retinoic	NULL
acid	NULL
and	NULL
thyroid	NULL
hormone	NULL
receptors	NULL
.	NULL

EMBO	NULL
J	NULL
11:1409	NULL
,	NULL
1992	NULL
12	NULL
.	NULL

Marks	NULL
MS	NULL
,	NULL
Hallenbeck	NULL
PL	NULL
,	NULL
Nagata	NULL
T	NULL
,	NULL
Segars	NULL
JH	NULL
,	NULL
Appella	NULL
E	NULL
,	NULL
Nikodem	NULL
VM	NULL
,	NULL
Ozato	NULL
K	NULL
:	NULL
H-2RIIBP	NULL
(	NULL
RXR/3	NULL
)	NULL
heterodimerization	NULL
provides	NULL
a	NULL
mechanism	NULL
for	NULL
combinatorial	NULL
diversity	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
retinoic	NULL
acid	NULL
and	NULL
thyroid	NULL
hormone	NULL
responsive	NULL
genes	NULL
.	NULL

EMBO	NULL
J	NULL
11:1419	NULL
,	NULL
1992	NULL
13	NULL
.	NULL

Mangelsdorf	NULL
DJ	NULL
,	NULL
Borgmeyer	NULL
U	NULL
,	NULL
Heyman	NULL
RA	NULL
,	NULL
Zhou	NULL
JY	NULL
,	NULL
Ong	NULL
ES	NULL
,	NULL
Oro	NULL
AE	NULL
,	NULL
Kakizuka	NULL
A	NULL
,	NULL
Evans	NULL
RM	NULL
:	NULL
Characterization	NULL
of	NULL
three	NULL
RXR	NULL
genes	NULL
that	NULL
mediate	NULL
the	NULL
action	NULL
of	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
.	NULL

Genes	NULL
Dev	NULL
6:329	NULL
,	NULL
1992	NULL
14	NULL
.	NULL

Heyman	NULL
RA	NULL
,	NULL
Mangelsdorf	NULL
DF	NULL
,	NULL
Dyck	NULL
JA	NULL
,	NULL
Stein	NULL
RB	NULL
,	NULL
Eichele	NULL
G	NULL
,	NULL
Evans	NULL
RM	NULL
,	NULL
Thaler	NULL
C	NULL
:	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
is	NULL
a	NULL
high	NULL
affinity	NULL
ligand	NULL
for	NULL
the	NULL
retinoid	NULL
X	NULL
receptor	NULL
.	NULL

Cell	NULL
68:397	NULL
,	NULL
1992	NULL
15	NULL
.	NULL

Levin	NULL
AA	NULL
,	NULL
Sturzenbecker	NULL
LJ	NULL
,	NULL
Kazmer	NULL
S	NULL
,	NULL
Bosakowski	NULL
T	NULL
,	NULL
Hu-selton	NULL
C	NULL
,	NULL
Allenby	NULL
G	NULL
,	NULL
Speck	NULL
J	NULL
,	NULL
Kratzeisen	NULL
C	NULL
,	NULL
Rosenberger	NULL
M	NULL
,	NULL
Lovey	NULL
A	NULL
,	NULL
Grippo	NULL
JF	NULL
:	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
sterecisomer	NULL
binds	NULL
and	NULL
activates	NULL
the	NULL
nuclear	NULL
receptor	NULL
RXRa	NULL
.	NULL

Nature	NULL
355:359	NULL
,	NULL
1992	NULL
16	NULL
.	NULL

Umesono	NULL
K	NULL
,	NULL
Murakami	NULL
KK	NULL
,	NULL
Thompson	NULL
CC	NULL
,	NULL
Evans	NULL
RM	NULL
:	NULL
Direct	NULL
repeats	NULL
as	NULL
selective	NULL
response	NULL
elements	NULL
for	NULL
the	NULL
thyroid	NULL
hormone	NULL
,	NULL
retinoic	NULL
acid	NULL
,	NULL
and	NULL
vitamin	NULL
D3	NULL
receptors	NULL
.	NULL

Nature	NULL
65:1255	NULL
,	NULL
1991	NULL
17	NULL
.	NULL

Mangelsdorf	NULL
DJ	NULL
,	NULL
Umesono	NULL
K	NULL
,	NULL
Kliewer	NULL
SA	NULL
,	NULL
Borgmeyer	NULL
U	NULL
,	NULL
Ong	NULL
ES	NULL
,	NULL
Evans	NULL
RM	NULL
:	NULL
A	NULL
direct	NULL
repeat	NULL
in	NULL
the	NULL
cellular	NULL
retinol-binding	NULL
protein	NULL
type	NULL
II	NULL
gene	NULL
confers	NULL
differential	NULL
regulation	NULL
by	NULL
RXR	NULL
and	NULL
RAR	NULL
.	NULL

Cell	NULL
66:555	NULL
,	NULL
1991	NULL
18	NULL
.	NULL

Zhang	NULL
X-k	NULL
,	NULL
Lehmann	NULL
J	NULL
,	NULL
Hoffmann	NULL
B	NULL
,	NULL
Dawson	NULL
MI	NULL
,	NULL
Cameron	NULL
J	NULL
,	NULL
Graupner	NULL
G	NULL
,	NULL
Hermann	NULL
T	NULL
,	NULL
Tran	NULL
P	NULL
,	NULL
Pfahl	NULL
M	NULL
;	NULL
Homodimer	NULL
formation	NULL
of	NULL
retinoid	NULL
X	NULL
receptor	NULL
induced	NULL
by	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
.	NULL

Nature	NULL
358:587	NULL
,	NULL
1992	NULL
19	NULL
.	NULL

Hodges	NULL
RE	NULL
,	NULL
Sauberlich	NULL
HE	NULL
,	NULL
Canham	NULL
JE	NULL
,	NULL
Wallace	NULL
DL	NULL
,	NULL
Rucker	NULL
RB	NULL
,	NULL
Mejia	NULL
LA	NULL
:	NULL
Hematopoietic	NULL
studies	NULL
in	NULL
vitamin	NULL
A	NULL
deficiency	NULL
.	NULL

Am	NULL
J	NULL
Clin	NULL
Nutr	NULL
31:876	NULL
,	NULL
1978	NULL
20	NULL
.	NULL

Mejia	NULL
LA	NULL
,	NULL
Hodges	NULL
RE	NULL
,	NULL
Rucker	NULL
RB	NULL
:	NULL
Clinical	NULL
signs	NULL
of	NULL
anemia	NULL
in	NULL
vitamin	NULL
A-deficient	NULL
rats	NULL
.	NULL

Am	NULL
J	NULL
Clin	NULL
Nutr	NULL
32:1439	NULL
,	NULL
1979	NULL
21	NULL
.	NULL

Douer	NULL
D	NULL
,	NULL
Koefflee	NULL
HP	NULL
:	NULL
Retinoic	NULL
acid	NULL
enhances	NULL
growth	NULL
of	NULL
human	NULL
early	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
69:1039	NULL
,	NULL
1982	NULL
22	NULL
.	NULL

Fabian	NULL
I	NULL
,	NULL
Shvartzmayer	NULL
S	NULL
:	NULL
Effect	NULL
of	NULL
a	NULL
new	NULL
retinoidal	NULL
benzoic	NULL
acid	NULL
derivative	NULL
on	NULL
normal	NULL
human	NULL
hematopoietic	NULL
progenitor	NULL
cell	NULL
growth	NULL
in	NULL
vitro	NULL
.	NULL

Cancer	NULL
Res	NULL
46:2413	NULL
,	NULL
1986	NULL
23	NULL
.	NULL

Correa	NULL
PN	NULL
,	NULL
Axelrad	NULL
AA	NULL
:	NULL
Production	NULL
of	NULL
erythropoietic	NULL
bursts	NULL
by	NULL
progenitor	NULL
cells	NULL
from	NULL
adult	NULL
human	NULL
peripheral	NULL
blood	NULL
in	NULL
an	NULL
improved	NULL
serum-free	NULL
medium	NULL
:	NULL
Role	NULL
of	NULL
insulinlike	NULL
growth	NULL
factor	NULL
1	NULL
.	NULL

Blood	NULL
78:2823	NULL
,	NULL
1991	NULL
24	NULL
.	NULL

Correa	NULL
PN	NULL
,	NULL
Axelrad	NULL
AA	NULL
:	NULL
Retinyl	NULL
acetate	NULL
and	NULL
all-trans-retinoic	NULL
acid	NULL
enhance	NULL
erythroid	NULL
colony	NULL
formation	NULL
in	NULL
vitro	NULL
by	NULL
circulating	NULL
human	NULL
progenitors	NULL
in	NULL
an	NULL
improved	NULL
serum-free	NULL
medium	NULL
.	NULL

Int	NULL
J	NULL
Cell	NULL
Clon	NULL
10:286	NULL
,	NULL
1992	NULL
1735	NULL
25	NULL
.	NULL

Sakashita	NULL
A	NULL
,	NULL
Kizaki	NULL
M	NULL
,	NULL
Pakkala	NULL
S	NULL
,	NULL
Schiller	NULL
G	NULL
,	NULL
Tsuruoka	NULL
N	NULL
,	NULL
Tomosaki	NULL
R	NULL
,	NULL
Cameron	NULL
JF	NULL
,	NULL
Dawson	NULL
MI	NULL
,	NULL
Koeffier	NULL
HP	NULL
:	NULL
9-cis-retinoic	NULL
acid	NULL
:	NULL
Effects	NULL
on	NULL
normal	NULL
and	NULL
leukemic	NULL
hematopoiesis	NULL
in	NULL
vitro	NULL
.	NULL

Blood	NULL
81:1009	NULL
,	NULL
1993	NULL
26	NULL
.	NULL

Swanson	NULL
G	NULL
,	NULL
Picozzi	NULL
V	NULL
,	NULL
Morgan	NULL
R	NULL
,	NULL
Hecht	NULL
F	NULL
,	NULL
Greenberg	NULL
P	NULL
:	NULL
Responses	NULL
of	NULL
hemopoietic	NULL
precursors	NULL
to	NULL
13-cis	NULL
retinoic	NULL
acid	NULL
and	NULL
1,25	NULL
dihydroxyvitamin	NULL
D3	NULL
in	NULL
the	NULL
myelodysplastic	NULL
syndromes	NULL
.	NULL

Blood	NULL
67:1154	NULL
,	NULL
1986	NULL
27	NULL
.	NULL

Van	NULL
Bockstaele	NULL
DR	NULL
,	NULL
Lenjou	NULL
M	NULL
,	NULL
Snoeck	NULL
HW	NULL
,	NULL
Lardon	NULL
F	NULL
,	NULL
Stryckmans	NULL
P	NULL
,	NULL
Peetermans	NULL
ME	NULL
:	NULL
Direct	NULL
effects	NULL
of	NULL
13-cis	NULL
and	NULL
all-trans	NULL
retinoic	NULL
acid	NULL
on	NULL
normal	NULL
bone	NULL
marrow	NULL
(	NULL
BM	NULL
)	NULL
progenitors	NULL
:	NULL
Comparative	NULL
study	NULL
on	NULL
BM	NULL
mononuclear	NULL
ceils	NULL
and	NULL
on	NULL
isolated	NULL
CD34*	NULL
BM	NULL
cells	NULL
.	NULL

Ann	NULL
Hematol	NULL
66:61	NULL
,	NULL
1993	NULL
28	NULL
.	NULL

Labbaye	NULL
C	NULL
,	NULL
Valtieri	NULL
M	NULL
,	NULL
Testa	NULL
U	NULL
,	NULL
Giampaolo	NULL
A	NULL
,	NULL
Meccia	NULL
E	NULL
,	NULL
Sterpetti	NULL
P	NULL
,	NULL
Parolini	NULL
I	NULL
,	NULL
Pelosi	NULL
E	NULL
,	NULL
Bulgarini	NULL
D	NULL
,	NULL
Cayre	NULL
YE	NULL
,	NULL
Peschle	NULL
C	NULL
:	NULL
Retinoic	NULL
acid	NULL
downmodulates	NULL
erythroid	NULL
differentiation	NULL
and	NULL
GATA1	NULL
expression	NULL
in	NULL
purified	NULL
adult-progenitor	NULL
culture	NULL
.	NULL

Blood	NULL
83:651	NULL
,	NULL
1994	NULL
29	NULL
.	NULL

Tohda	NULL
S	NULL
,	NULL
Minden	NULL
MD	NULL
,	NULL
McCulloch	NULL
EA	NULL
:	NULL
Interactions	NULL
between	NULL
retinoic	NULL
acid	NULL
and	NULL
colony-stimulating	NULL
factors	NULL
affecting	NULL
the	NULL
blast	NULL
cells	NULL
of	NULL
acute	NULL
myeloblastic	NULL
leukemia	NULL
.	NULL

Leukemia	NULL
5:951	NULL
,	NULL
1991	NULL
30	NULL
.	NULL

Smeland	NULL
EB	NULL
,	NULL
Rusten	NULL
L	NULL
,	NULL
Jacobsen	NULL
SEW	NULL
,	NULL
Skrede	NULL
B	NULL
,	NULL
Blomhoff	NULL
R	NULL
,	NULL
Wang	NULL
MY	NULL
,	NULL
Funderud	NULL
S	NULL
$	NULL
,	NULL
Kvalheim	NULL
G	NULL
,	NULL
Blomhoff	NULL
HK	NULL
:	NULL
All-trans	NULL
retinoic	NULL
acid	NULL
directly	NULL
inhibits	NULL
granulocyte	NULL
colony-stimulating	NULL
factor-induced	NULL
proliferation	NULL
of	NULL
CD34*	NULL
human	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
.	NULL

Blood	NULL
84:2940	NULL
,	NULL
1994	NULL
31	NULL
.	NULL

Kurokawa	NULL
R	NULL
,	NULL
DiRenzo	NULL
J	NULL
,	NULL
Boehm	NULL
M	NULL
,	NULL
Sugarman	NULL
J	NULL
,	NULL
Gloss	NULL
B	NULL
,	NULL
Rosenfeld	NULL
MG	NULL
,	NULL
Heyman	NULL
RA	NULL
,	NULL
Glass	NULL
CK	NULL
:	NULL
Regulation	NULL
of	NULL
retinoid	NULL
signalling	NULL
by	NULL
receptor	NULL
polarity	NULL
and	NULL
allosteric	NULL
control	NULL
of	NULL
ligand	NULL
binding	NULL
.	NULL

Nature	NULL
371:528	NULL
,	NULL
1994	NULL
32	NULL
.	NULL

Gehr	NULL
G	NULL
,	NULL
Gentz	NULL
R	NULL
,	NULL
Brockhaus	NULL
M	NULL
,	NULL
Loetscher	NULL
H	NULL
,	NULL
Lesslauer	NULL
W	NULL
;	NULL
:	NULL
Both	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
types	NULL
mediate	NULL
proliferative	NULL
signals	NULL
in	NULL
human	NULL
mononuclear	NULL
cell	NULL
activation	NULL
.	NULL

J	NULL
Immunol	NULL
149:911	NULL
,	NULL
1992	NULL
â	NULL
33	NULL
.	NULL

Dasch	NULL
JR	NULL
,	NULL
Pace	NULL
DR	NULL
,	NULL
Waegell	NULL
W	NULL
,	NULL
Inenaga	NULL
D	NULL
,	NULL
Ellingsworth	NULL
L.	NULL
:	NULL
Monoclonal	NULL
antibodies	NULL
recognizing	NULL
transforming	NULL
growth	NULL
factor-9	NULL
.	NULL

J	NULL
Immunol	NULL
142	NULL
;	NULL
:1536	NULL
,	NULL
1989	NULL
34	NULL
.	NULL

Barral-Netto	NULL
M	NULL
,	NULL
Barral	NULL
A	NULL
,	NULL
Brownell	NULL
CE	NULL
,	NULL
Skeiky	NULL
YAW	NULL
,	NULL
Ellingsworth	NULL
L	NULL
,	NULL
Twardzik	NULL
DR	NULL
,	NULL
Reed	NULL
SG	NULL
:	NULL
Transforming	NULL
growth	NULL
factor-	NULL
$	NULL
in	NULL
leishmanial	NULL
infection	NULL
:	NULL
A	NULL
parasite	NULL
escape	NULL
mechanism	NULL
.	NULL

Science	NULL
257:545	NULL
,	NULL
1992	NULL
35	NULL
.	NULL

Smeland	NULL
EB	NULL
,	NULL
Funderud	NULL
S	NULL
,	NULL
Kvalheim	NULL
G	NULL
,	NULL
Gaudernack	NULL
G	NULL
,	NULL
Rasmussen	NULL
A-M	NULL
,	NULL
Rusten	NULL
L	NULL
,	NULL
Wang	NULL
MY	NULL
,	NULL
Tindle	NULL
RW	NULL
,	NULL
Blomhoff	NULL
HK	NULL
,	NULL
Egeland	NULL
T	NULL
:	NULL
Isolation	NULL
and	NULL
characterization	NULL
of	NULL
human	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
:	NULL
An	NULL
effective	NULL
method	NULL
for	NULL
positive	NULL
selection	NULL
of	NULL
CD34*	NULL
cells	NULL
.	NULL

Leukemia	NULL
6:845	NULL
,	NULL
1992	NULL
36	NULL
.	NULL

Egeland	NULL
T	NULL
,	NULL
Gaudernack	NULL
G	NULL
:	NULL
CD34	NULL
:	NULL
The	NULL
gateway	NULL
to	NULL
the	NULL
study	NULL
of	NULL
lymphohematopoietic	NULL
progenitor	NULL
and	NULL
leukemic	NULL
cells	NULL
.	NULL

Immunologist	NULL
2:65	NULL
,	NULL
1994	NULL
37	NULL
.	NULL

Spangrude	NULL
GJ	NULL
,	NULL
Heimfeld	NULL
SH	NULL
,	NULL
Weissman	NULL
IL	NULL
:	NULL
Purification	NULL
and	NULL
characterization	NULL
of	NULL
mouse	NULL
hematopoietic	NULL
stem	NULL
cells	NULL
.	NULL

Science	NULL
241:58	NULL
,	NULL
1988	NULL
38	NULL
.	NULL

Rusten	NULL
LS	NULL
,	NULL
Jacobsen	NULL
SEW	NULL
,	NULL
Kaalhus	NULL
O	NULL
,	NULL
Veiby	NULL
OP	NULL
,	NULL
Funderud	NULL
S	NULL
,	NULL
Smeland	NULL
EB	NULL
:	NULL
Functional	NULL
differences	NULL
between	NULL
CD38~	NULL
and	NULL
DR~	NULL
subfractions	NULL
of	NULL
CD34*	NULL
bone	NULL
marrow	NULL
cells	NULL
.	NULL

Blood	NULL
84:1473	NULL
,	NULL
1994	NULL
39	NULL
.	NULL

Kumar	NULL
V	NULL
,	NULL
Green	NULL
S	NULL
,	NULL
Staub	NULL
A	NULL
,	NULL
Chambon	NULL
P	NULL
:	NULL
Localisation	NULL
of	NULL
the	NULL
oestradiol-binding	NULL
and	NULL
putative	NULL
DNA-binding	NULL
domains	NULL
of	NULL
the	NULL
human	NULL
oestrogen	NULL
receptor	NULL
.	NULL

EMBO	NULL
J	NULL
5:2231	NULL
,	NULL
1986	NULL
40	NULL
.	NULL

Jacobsen	NULL
SEW	NULL
,	NULL
Fahlman	NULL
C	NULL
,	NULL
Blomhoff	NULL
HK	NULL
,	NULL
Okkenhaug	NULL
C	NULL
,	NULL
Rusten	NULL
LS	NULL
,	NULL
Smeland	NULL
EB	NULL
:	NULL
All-trans	NULL
and	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
:	NULL
Potent	NULL
direct	NULL
inhibitors	NULL
of	NULL
primitive	NULL
murine	NULL
hematopoietic	NULL
progenitors	NULL
in	NULL
vitro	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
179:1665	NULL
,	NULL
1994	NULL
41	NULL
.	NULL

Hatzfeld	NULL
J	NULL
,	NULL
Li	NULL
ML	NULL
,	NULL
Brown	NULL
EL	NULL
,	NULL
Sookdeo	NULL
H	NULL
,	NULL
Levesque	NULL
JP	NULL
,	NULL
O'Toole	NULL
T	NULL
,	NULL
Gurney	NULL
C	NULL
,	NULL
Clark	NULL
SC	NULL
,	NULL
Hatzfeld	NULL
A	NULL
:	NULL
Release	NULL
of	NULL
early	NULL
human	NULL
hematopoietic	NULL
progenitors	NULL
from	NULL
quiescence	NULL
by	NULL
antisense	NULL
transforming	NULL
growth	NULL
factor	NULL
#	NULL
,	NULL
or	NULL
Rb	NULL
oligonucleotides	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
174925	NULL
,	NULL
1991	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1736	NULL
42	NULL
.	NULL

Falk	NULL
LA	NULL
,	NULL
De	NULL
Benedetti	NULL
F	NULL
,	NULL
Lohrey	NULL
N	NULL
,	NULL
Birchenall-Roberts	NULL
MC	NULL
,	NULL
Ellingsworth	NULL
LW	NULL
,	NULL
Faltynek	NULL
CR	NULL
,	NULL
Ruscetti	NULL
FW	NULL
:	NULL
Induction	NULL
of	NULL
transforming	NULL
growth	NULL
factor-8	NULL
,	NULL
receptor	NULL
expression	NULL
and	NULL
TGF-	NULL
,	NULL
protein	NULL
production	NULL
in	NULL
retinoic	NULL
acid-treated	NULL
HL-60	NULL
cells	NULL
:	NULL
Possible	NULL
TGF-	NULL
,	NULL
-mediated	NULL
autocrine	NULL
inhibition	NULL
.	NULL

Blood	NULL
77:1248	NULL
,	NULL
1991	NULL
43	NULL
.	NULL

Caux	NULL
C	NULL
,	NULL
Favre	NULL
C	NULL
,	NULL
Saeland	NULL
S	NULL
,	NULL
Duvert	NULL
V	NULL
,	NULL
Durand	NULL
I	NULL
,	NULL
Mannoni	NULL
P	NULL
,	NULL
Banchereau	NULL
J	NULL
:	NULL
Potentiation	NULL
of	NULL
early	NULL
hematopoiesis	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
is	NULL
followed	NULL
by	NULL
inhibition	NULL
of	NULL
granulopoietic	NULL
differentiation	NULL
and	NULL
proliferation	NULL
.	NULL

Blood	NULL
78:635	NULL
,	NULL
1991	NULL
44	NULL
.	NULL

Rusten	NULL
LS	NULL
,	NULL
Jacobsen	NULL
FW	NULL
,	NULL
Lesslauer	NULL
W	NULL
,	NULL
Loetscher	NULL
H	NULL
,	NULL
Smeland	NULL
EB	NULL
,	NULL
Jacobsen	NULL
SEW	NULL
:	NULL
Bifunctional	NULL
effects	NULL
of	NULL
TNF-a	NULL
on	NULL
the	NULL
growth	NULL
of	NULL
mature	NULL
and	NULL
primitive	NULL
human	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
:	NULL
Involvement	NULL
of	NULL
p55	NULL
and	NULL
p75	NULL
TNF	NULL
receptors	NULL
.	NULL

Blood	NULL
83:3152	NULL
,	NULL
1994	NULL
45	NULL
.	NULL

Rusten	NULL
LS	NULL
,	NULL
Jacobsen	NULL
SEW	NULL
:	NULL
TNF-a	NULL
directly	NULL
inhibits	NULL
human	NULL
erythropoiesis	NULL
in	NULL
vitro	NULL
:	NULL
Role	NULL
of	NULL
p55	NULL
and	NULL
p75	NULL
TNF	NULL
receptors	NULL
.	NULL

Blood	NULL
85:989	NULL
,	NULL
1995	NULL
46	NULL
.	NULL

Lehmann	NULL
JM	NULL
,	NULL
Jong	NULL
L	NULL
,	NULL
Fanjul	NULL
A	NULL
,	NULL
Cameron	NULL
JF	NULL
,	NULL
Lu	NULL
XP	NULL
,	NULL
Haefner	NULL
P.	NULL
Dawson	NULL
MI	NULL
,	NULL
Pfahl	NULL
M	NULL
:	NULL
Retinoids	NULL
selective	NULL
for	NULL
retinoid	NULL
X	NULL
receptor	NULL
response	NULL
pathways	NULL
.	NULL

Science	NULL
258:1944	NULL
,	NULL
1992	NULL
47	NULL
.	NULL

Napoli	NULL
JL	NULL
:	NULL
Retinoic	NULL
acid	NULL
homeostasis	NULL
:	NULL
prospective	NULL
roles	NULL
of	NULL
B-carotene	NULL
,	NULL
retinol	NULL
,	NULL
CRBP	NULL
,	NULL
and	NULL
CRABP	NULL
,	NULL
in	NULL
Blomhoff	NULL
R	NULL
(	NULL
ed	NULL
)	NULL
:	NULL
Vitamin	NULL
A	NULL
in	NULL
Health	NULL
and	NULL
Disease	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Dekker	NULL
,	NULL
1994	NULL
,	NULL
p	NULL
135	NULL
48	NULL
.	NULL

Jacobsen	NULL
SEW	NULL
,	NULL
Ruscetti	NULL
FW	NULL
,	NULL
Ortiz	NULL
M	NULL
,	NULL
Gooya	NULL
JM	NULL
,	NULL
Keller	NULL
JR	NULL
:	NULL
The	NULL
growth	NULL
response	NULL
of	NULL
Lin	NULL
~Thy-1*	NULL
hematopoietic	NULL
progenitors	NULL
to	NULL
cytokines	NULL
is	NULL
determined	NULL
by	NULL
the	NULL
balance	NULL
between	NULL
synergy	NULL
of	NULL
multiple	NULL
stimulators	NULL
and	NULL
negative	NULL
cooperation	NULL
of	NULL
multiple	NULL
inhibitors	NULL
.	NULL

Exp	NULL
Hematol	NULL
22:985	NULL
,	NULL
1994	NULL
RUSTEN	NULL
ET	NULL
AL	NULL
49	NULL
.	NULL

Rusten	NULL
LS	NULL
,	NULL
Smeland	NULL
EB	NULL
,	NULL
Jacobsen	NULL
FW	NULL
,	NULL
Lien	NULL
E	NULL
,	NULL
Lesslauer	NULL
W	NULL
,	NULL
Loetscher	NULL
H	NULL
,	NULL
Dubois	NULL
CM	NULL
,	NULL
Jacobsen	NULL
SEW	NULL
:	NULL
TNF-a	NULL
inhibits	NULL
stem	NULL
cell	NULL
factor-induced	NULL
proliferation	NULL
of	NULL
human	NULL
bone	NULL
marrow	NULL
progenitor	NULL
cells	NULL
in	NULL
vitro	NULL
:	NULL
Role	NULL
of	NULL
p55	NULL
and	NULL
p75	NULL
TNF	NULL
receptors	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
94:165	NULL
,	NULL
1994	NULL
50	NULL
.	NULL

Ono	NULL
K	NULL
,	NULL
Waki	NULL
Y	NULL
,	NULL
Takeda	NULL
K	NULL
:	NULL
Hypervitaminosis	NULL
A	NULL
:	NULL
A	NULL
contributing	NULL
factor	NULL
to	NULL
anemia	NULL
in	NULL
regular	NULL
dialysis	NULL
patients	NULL
.	NULL

Nephron	NULL
38:44	NULL
,	NULL
1984	NULL
51	NULL
.	NULL

Carman	NULL
JA	NULL
,	NULL
Hayes	NULL
CE	NULL
:	NULL
Abnormal	NULL
regulation	NULL
of	NULL
IFN-y	NULL
secretion	NULL
in	NULL
vitamin	NULL
A	NULL
deficiency	NULL
.	NULL

J	NULL
Immunol	NULL
147:1247	NULL
,	NULL
1991	NULL
52	NULL
.	NULL

Mamus	NULL
SW	NULL
,	NULL
Beck-Schroeder	NULL
S	NULL
,	NULL
Zanjani	NULL
ED	NULL
:	NULL
Suppression	NULL
of	NULL
normal	NULL
erythropoiesis	NULL
by	NULL
gamma	NULL
interferon	NULL
in	NULL
vitro	NULL
:	NULL
Role	NULL
of	NULL
mono-cytes	NULL
and	NULL
T	NULL
lymphocytes	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
75:1496	NULL
,	NULL
1985	NULL
53	NULL
.	NULL

Hodges	NULL
RE	NULL
,	NULL
Rucker	NULL
RB	NULL
,	NULL
Gardner	NULL
RH	NULL
:	NULL
Vitamin	NULL
A	NULL
deficiency	NULL
and	NULL
abnormal	NULL
metabolism	NULL
of	NULL
iron	NULL
.	NULL

Ann	NULL
NY	NULL
Acad	NULL
Sci	NULL
355:58	NULL
,	NULL
1980	NULL
54	NULL
.	NULL

Dawson	NULL
MI	NULL
,	NULL
Elstner	NULL
E	NULL
,	NULL
Kizaki	NULL
M	NULL
,	NULL
Chen	NULL
D-L	NULL
,	NULL
Pakkala	NULL
S	NULL
,	NULL
Kerner	NULL
B	NULL
,	NULL
Koeffler	NULL
HP	NULL
:	NULL
Myeloid	NULL
differentiation	NULL
mediated	NULL
through	NULL
retinoic	NULL
acid	NULL
receptor/retinoic	NULL
X	NULL
receptor	NULL
(	NULL
RXR	NULL
)	NULL
not	NULL
RXR/RXR	NULL
pathway	NULL
.	NULL

Blood	NULL
84:446	NULL
,	NULL
1994	NULL
55	NULL
.	NULL

Kastner	NULL
P	NULL
,	NULL
Chambon	NULL
P.	NULL
Leid	NULL
M	NULL
:	NULL
Role	NULL
of	NULL
nuclear	NULL
retinoic	NULL
acid	NULL
receptors	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
,	NULL
in	NULL
Blomhoff	NULL
R	NULL
(	NULL
ed	NULL
)	NULL
:	NULL
Vitamin	NULL
A	NULL
in	NULL
Health	NULL
and	NULL
Disease	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Dekker	NULL
,	NULL
1994	NULL
,	NULL
p	NULL
189	NULL
56	NULL
.	NULL

Kliewer	NULL
SA	NULL
,	NULL
Umesono	NULL
K	NULL
,	NULL
Evans	NULL
RM	NULL
,	NULL
Mangelsdorf	NULL
DJ	NULL
:	NULL
The	NULL
retinoid	NULL
X	NULL
receptors	NULL
:	NULL
modulators	NULL
of	NULL
multiple	NULL
hormonal	NULL
signaling	NULL
pathways	NULL
,	NULL
in	NULL
Blomhoff	NULL
R	NULL
(	NULL
ed	NULL
)	NULL
:	NULL
Vitamin	NULL
A	NULL
in	NULL
Health	NULL
and	NULL
Disease	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
.	NULL

Dekker	NULL
,	NULL
1994	NULL
,	NULL
p	NULL
239	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Â®	NULL
blO	NULL
0d	NULL
1996	NULL
87	NULL
:	NULL
1728-1736	NULL
The	NULL
RAR-RXR	NULL
as	NULL
well	NULL
as	NULL
the	NULL
RXR-RXR	NULL
pathway	NULL
is	NULL
involved	NULL
in	NULL
signaling	NULL
growth	NULL
inhibition	NULL
of	NULL
human	NULL
CD34+	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
4	NULL
peRiCAy	NULL
_	NULL
5	NULL
,	NULL
'	NULL
_	NULL
>	NULL
,	NULL
#	NULL
04	NULL
;	NULL
Â©1004	NULL
@	NULL
207	NULL
LS	NULL
Rusten	NULL
,	NULL
|	NULL
Dybedal	NULL
,	NULL
HK	NULL
Blomhoff	NULL
,	NULL
R	NULL
Blomhoff	NULL
,	NULL
EB	NULL
Smeland	NULL
and	NULL
SE	NULL
Jacobsen	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/87/5/1728.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

